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ABSTRACT
The purpose of this study was to examine the impact of long-term exposure to 
corticosterone (CC) and chronic zinc-deprivation (ZnD) on memory performance and 
hippocampal damage in rats. Previous work has examined the impact of exposure to CC 
or the impact of ZnD, but no previous work has examined the combined impact on 
memory performance. Previous work suggests that chronic exposure to CC or ZnD 
results in hippocampal damage and memory deficits.
The present study utilized a broader range of memorv tests than previous studies and 
administered the memory tests early and late in the umc pctiou of CC exposure and ZnD. 
CC is released as a part of the stress response and is initially beneficial to the organism in 
maintaining homeostasis. However, with chronic exposure to stress and subsequent 
chronic CC release, damage to the cell bodies and neurons of the hippocampus have been 
found. This is problematic because the hippocampus plays a role in memory and learning 
mechanisms. Memory problems are also present in stress-related disorders such as post- 
traumatic stress disorder (Bremner, 1999) and depression (Sheline et al., 1996).
The hypotheses of this study were that hippocampal degeneration as a result of long­
term CC exposure and ZnD would result in decreased long- and short-term spatial 
memory in Sprague-Dawley rats with a greater decrease in memory in ZnD rats as 
compared to ZnA (Zinc-adequate) animals. Degeneration of the neurons of the 
hippocampus would also be apparent in the CC treated animals with more degeneration
xiv
exhibited in the ZnD rats than the ZnA animals, and this would correspond to greater 
deficits found in memory.
Results indicated a general decrease in performance was found for the CC animals as 
compared to control animals on the memory tasks. A decrease in the hippocampus area 
CA3 pyramidal cell layer width was observed in the animals treated with CC. 
Performance on the radial arm maze was significantly correlated with the width of the 
CA3 pyramidal cell layer. Performance on the water maze was significantly correlated 
with the concentration of zinc in the vesicles in the CA1 and CA3 areas of the 
hippocampus.
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CHAPTER 1
INTRODUCTION
Glucocorticoids (GCs) are a class of adrenal cortical hormones that are activated 
during stress. In humans the primary glucocorticoid is cortisol, in rats it is corticosterone. 
In later portions of the stress response, glucocorticoids are released in order to mobilize 
energy, increase cardiovascular functioning, to inhibit unnecessary processes (such as 
digestion) and attempt to regain homeostasis. The hypothalamic-pituitary-adrenal axis 
■•Ues the production of glucocorticoids. Normally, glucocorticoids are released 
during specific times of the circadian rhythm with increased secretion in the morning for 
humans and in the evening for rats, which is related to the diurnal cycle. Additional 
release of GCs during stress depends on the intensity, duration and type of stimulus. In 
individuals with tumors, symptoms of stress, depression and alcoholism increased release 
of GCs have also been found (Buckingham, Cowell, Gillies, Herbinson & Steel, 1997).
Carroll et al. (1981) administered a dexamethasone suppression test to 438 
subjects along with a diagnostic interview to detect the presence of endogenous 
depression. In those subjects with symptoms indicative of depression, abnormal cortisol 
concentrations were found in 98% of the subjects. Young et al. (1991) found that this 
abnormality in cortisol levels may be due to inhibition of the glucocorticoid feedback 
system a system which is responsible for the regulation of the amount of circulating 
cortisol, this inhibition results
2in abnormal levels of cortisol. In animals, stress results in reduced activity, freezing and 
increased startle responses (Levine & Ursin, 1991).
Corticosterone and the Hippocampus
The hippocampal formation is a portion of the limbic system and is composed of the 
subiculm, hippocampus and the dentate gyrus. The hippocampus is actually composed of 
three cell layers, the outer molecular layer contains the afferent axons and dendrites that 
radiate from the middle layer, the pyramidal layer contains the efferent neurons, and the 
inner polymorphic layer which contains the axons of the pyramidal cell neurons (Haines, 
1997). The afferent (pathway between sense organ and brain) perforant hippocampal 
pathway exits the sensory organs and then connects to the primary and secondary sensory 
cortices, to the entorhinal cortex and then to the hippocampus. The fibers running ~ ' 
the superficial layers of the entorhinal cortex are the main afferent pathways to the 
hippocampus with fibers going to all three major hippocampal structures, the dentate 
gyrus, CA1 and CA3. The cells in the dentate gyrus in turn send mossy fibers to CA3. 
The CA3 then sends the Schaffer-commissural fibers to the CA1. Efferent (pathway 
between brain and muscles or glands) fiber pathways lead from the hippocampus, 
through the deep layers of the entorhinal cortex and to the ventral striatum. These two 
areas then send efferent fibers to the hindbrain, to the motor system and also to the 
dorsomedial nucleus of the thalamus, which in turn connects to the frontal cortex (Gluck 
& Granger, 1993).
The hippocampal formation is thought to consolidate immediate and short-term 
memories into long-term memories. Consolidation is thought to occur by the 
hippocampus using information from the sensory and motor cortices and combining them
3with the memory that is being formed thus allowing us to remember the context of a 
particular memory (Carlson, 2001). One way this may occur is through long-term 
potentiation in which a synapse fires in a particular pattern in response to a particular 
stimuli. This pattern of firing increases the probability that the stimuli will continue to 
activate the targeted cell. Long-term potentiation is thought to result from the integration 
of several synaptic inputs and this leads to the formation of a memory (Haines, 1997).
The implication that damage to the hippocampus effects memory was first discovered 
in the patient H.M. who had both the left and right hippocampi surgically removed in 
order to control a seizure disorder. H.M. developed anterograde amnesia in which he was 
unable to learn and form new long-term memories (Scoville & Milner, 1957). Past 
research has also demonstrated that in rats, lesions o ftV' ’■' ^mpal formation 
produced deficits in performance on a radial-arm maze (Handelmann & Olton; 1981 
Kesner, 1985) and a 16-hole memory board task (Oades, 1981). On the radial-arm maze 
task used in this study the animal was assessed on whether it remembered which of 
several arms of a radial maze were already visited. In the 16-hole memory board task, 
animals are required to search for four pellets hidden in 16 holes in the testing cage. On 
both tasks, errors occur when the animal visits an arm or a hole that had already been 
visited, testing the animal’s memory and use of the hippocampus. These tasks illustrate 
the role of the hippocampus in memory.
Effect of Corticosterone on the Hippocampus and Memory
Stress has been theorized as a cause of hippocampal damage resulting from GC 
release. A few days of stress endangers the hippocampus, over a few weeks, increased 
levels of GC secretion cause dendritic atrophy and after a few months of chronic
4exposure to stress, permanent loss of hippocampal neurons occurs (Sapolsky, 1996).
This loss of hippocampal neurons was demonstrated in a study by Sapolsky, Krey and 
McEwen (1985) who exposed Fisher 344 rats to daily injections of corticosterone in 
order to produce high plasma levels for three months. Extensive depletion of GC 
receptors, a loss of CA3 field cells, and an increase in the number of darkly stained cells 
in the CA3 field indicated several signs of neuronal destruction.
Several mechanisms of action have been proposed for the degeneration of 
hippocampal cells by GCs, including that GCs disrupt the availability of energy to 
hippocampal neurons by disrupting the transport of up to 15-30% of the glucose to 
hippocampal tissue. This percentage is very high considering that hippocampal neurons 
are very vulnerable, rely cr. f o survive, and cannot store glucose. GCs may also 
disrupt conversion of glutamate to glutamine. Glutamate is an excitatory 
neurotransmitter that activates the NMDA receptor, which allows excess calcium to enter 
hippocampal cells. Excess calcium may also lead to neuron death (Sapolsky, 1991).
Previous investigations of the direct impact of stress on hippocampal damage have 
also shown an indirect impact on memory. Bodnoff et al. (1995) investigated the effects 
of chronic corticosterone treatment on spatial memory and neuropathology of young (5 
months) and mid-aged (12 months) Long-Evans rats in three experiments. In Experiment 
1 corticosterone or cholesterol pellets that were implanted for one or three months and 
produced elevated corticosterone levels to 30 +/- 2 pg per day. In Experiment 2, rats 
were subjected to either social stress or a combination of stress and corticosterone 
implantation with 100 mg GC pellets for six months. In Experiment 3, animals were 
implanted with corticosterone pellets produced by Innovative Research that released a
5steady dosage for three months. The rats for the Experiment 3 were divided into a 
medium-concentration group with average corticosterone concentrations between 12-17 
pg/day, a high-concentration group with concentrations of 23-32 pg/day and a control 
group receiving cholesterol pellets. The rats were tested using the Morris (1984) water 
maze which requires the animal to find a submerged platform in a pool of opaque water 
using only distal cues. The dependent variables in the Morris water maze were distance 
swam, latency to the submerged platform and time swimming around the submerged 
platform. For Experiment 1, the administration of corticosterone had no effect on 
performance on the water maze after one month of treatment for either age groups. After 
three months of treatment there were significant increases for latency and distance
between corticosterone-treated and cholesterol-treated mid-aged animals on the 
water maze, while no differences were found in young animals due to effects of 
corticosterone treatment, implicating an increased vulnerability with age. In Experiment 
2, the group that received social stress showed higher plasma corticosterone 
concentrations, which were about two times the amount of control animals. The social 
stress animals also demonstrated impaired performance on the water maze with increased 
latency and swim distance. In Experiment 3, the rats that received high concentrations of 
corticosterone spent less time in the area around the submerged platform, impairing 
performance on the water maze with increased latency and distance swam. There were 
no significant differences found in neuron density in the CA1 and CA3 regions or cell 
size in Experiment 3. The medium and high-concentration corticosterone animals 
showed impaired excitability and short-term plasticity when tested with 
electrophysiological techniques. This study only examined the hippocampal tissue of the
6rats in Experiment 3. The lack of neuronal loss in the hippocampus, even in the presence 
of behavioral deficit, may depend on the strain of rats used. The results of this study are 
in conflict with other studies that have found hippocampal damage when given chronic 
doses of GC (Sapolsky, 1991, Sapolsky, Krey & McEwen, 1985) with Fisher 344 rats. 
There might be differences in calcium-dependent energy stores or glutamate activity 
between strains that have not been identified.
Quervin, Roozendaal, and McGaugh (1998) examined the effects of stress and GCs on 
retrieval from long-term memory in a series of studies. In these studies, young Sprague- 
Dawley rats (10-12 weeks old) were trained within eight trials to locate a submerged 
platform in a Morris water maze (Morris, 1984). Twenty-four hours later the rats 
received a retention trial. Prior to the retention trial, a total of three, 8mA foot shock' i< 
with duration of one s with five-s intervals between shocks were administered. The rats 
received the three shocks 2-, 30- or 240-min before the retention trial. The control group 
did not receive any shocks. The control group spent significantly more time swimming 
in the quadrant of the water maze in which the platform had originally been placed than 
the shocked rats and exhibited focused searching patterns. The only group of rats that 
showed significant impairment of memory was the group that received a shock 30 min 
before their retention trials who demonstrated random swimming patterns. However, 
when the total length of swimming paths was calculated, there was no significant 
difference across the groups of rats. This study found increased levels of corticosterone in 
the 30-min group after the retention trial that was significantly higher than the other 
groups. A follow-up study used subcutaneous doses of 50 mg/kg of metyrapone, a drug 
which decreases the synthesis of corticosterone. Metyrapone was injected 40 min before
7foot shock using the same Morris maze and retention trials as the previous study. The 
rats injected with metryapone did not exhibit significant increases in plasma 
corticosterone concentrations following foot shock and also did not show differences in 
maze performance as compared to control rats. A third study was conducted to further 
the understanding of GCs on memory retrieval in rats that were not exposed to stress.
The same Morris water maze task was used with retention tested 24 hours later. The rats 
were given 0.3, 1.0 or 3.0 mg/kg of corticosterone, subcutaneously, 30 min before the 
retention trial. A dose-dependent increase in plasma corticosterone concentrations was 
found and treatment with the two higher doses (1.0 and 3.0 mg/kg) significantly impaired 
retention on the water maze similar to the impairment that was seen after the foot shock 
given at 30 min. These results demonstrated that increa'-' ’ •'’ions of GCs might
inhibit retention from long-term memory.
McLay, Freeman and Zadina (1998) administered 150 mg GC pellets (Innovative 
Research) for 80 days followed by testing in the Barnes (1979) circular platform maze 
and the Morris (1984) water maze. The Barnes circular platform maze consists of a 
white, .95-m diameter circle with 12 holes spaced around the edges. Under one of these 
holes is a darkened escape chamber, which is always in the same place although the 
platform itself is rotated between trials. The dependent variables of the Barnes maze 
included distance traveled, errors, the amount of time moving or resting and time to 
escape. The corticosterone-treated animals demonstrated significantly more errors, 
distance traveled, and time to escape. On the Morris water maze, the cortisone-treated 
animals also exhibited longer latency to escape. The animals also lost a significant 
amount of body weight due to corticosterone treatment. The authors found no other
8effects of the treatment on temperature or health and also found no differences on open- 
field motor activity when compared to control animals.
The above research demonstrates that exposure to a stressor or to GCs results in 
impairment in Morris water maze and the Barnes circular platform maze performance. In 
addition, impaired excitability and short-term plasticity was found in medium to high 
corticosterone treated animals. Thus chronic exposure to stress can result in memory 
problems and hippocampal damage.
Effects of Zinc Deficiency on Behavior and Brain Morphology 
Another variable that can be attributed to memory problems is ZnD (Zinc- 
deprivation), which can also lead to hippocampal damage. The hippocampal formation 
contains the largest concentsAVVl-Z 'Zinc) with 30-40% more Zn than other regions 
of the brain. In particular the CA3 area of the hippocampal formation contains the most 
Zn per weight. Zn concentration in the mossy fibers is 100 times higher than in 
cerebrospinal fluid and 20 times higher than in blood plasma. The mossy fibers form a 
communication link within the hippocampal formation (Crawford & Harris, 1984).
Zn, as an essential trace element, is acquired through consumption of whole grains, 
meat, fish and shellfish. Reduced calorie or protein intake may lead to ZnD (Golub at al., 
1995). Another common cause of ZnD is the consumption of the many processed foods 
that are widely available today. These foods include canned or frozen vegetables in 
which the processing strips their Zn content, white bread, sugary foods and fatty snacks. 
These foods may replace Zn-rich foods. Although, the RDA (recommended daily 
allowance) of Zn for adult males is 15 mg/day and adult females is 12 mg/day, few 
Americans actually consume this amount. Penland (2000) stated “Research on beneficial
9effects of improved Zn nutrition for behavior and brain function is critically needed 
because Zn deficiency continues to be a modern health concern in both developing and 
developed countries” (p. 363S).
It has been shown that ZnD during gestation, lactation and juvenile development has 
an impact on the hippocampus and on activity and learning (e.g. Golub at al., 1983, Halas 
at al., 1983). In a review of the available research on zinc deficiency, Sandstead et al. 
(2000), qoncluded that ZnD has been shown to cause malformations during early brain 
development. In later development, abnormalities in brain function have also been found. 
Kawamoto and Halas (1984) exposed female, Long-Evans rats to a ZnA diet (25 jug 
Zn/g), a ZnD (0 jig Zn/g) diet or pair fed (fed same amount of ZnA diet as ZnD group 
~ A " r^ 100 days. After testing, the rats were euthanized, perfused, and the
hippocampal formation was examined. The hippocampal formation upon light and 
electron microscope examination appeared normal in all treatment groups. The mean 
area of each of eight measured sections of the hippocampal region was reduced in both 
the pair-fed and the ZnD rats as compared to control rats. Testing in a 17-arm maze 
resulted in the ZnD rats making significantly more errors than either of the other two 
groups. The ZnD rats also used less variety in patterns or strategies in maze running than 
the other two groups. A positive correlation between number of errors on the maze and 
the neuronal density of the dentate granule cells of the hippocampus was also found with 
greater neuron density associated with more errors on the maze.
One study has been done which compared the effects of ZnD between juvenile and 
adult rats. Gordon (1984) compared two age groups of rats, 35- and 300-day old rats on 
several behavioral tests to examine the effects of ZnD. Three dietary groups included a
10
ZnD group that received 1 ppm of Zn, a pair-fed group received 50 ppm of Zn, and a 
ZnA group received food containing 50 ppm of Zn. All groups were fed their prescribed 
diets for 52 days. A circular open-field test measured latency to leave a center circle, 
grooming, freezing, sectors entered, rearing and number of boli during the testing session. 
Both ZnD young and old groups exhibited decreased food intake, decreased body weight 
and decreased plasma Zn concentrations. The young ZnD rats also had conjunctivitis, 
alopecia, inflamed paws, urethitis and skin lesions. The older ZnD rats had only alopecia 
and skin lesions. The older ZnD rats had a longer latency to leave the center circle, less 
grooming time and entered fewer sectors of the field than the younger ZnD rats. No prior 
studies have examined the impact of ZnD on adult rats (> 5 months age).
Rationale for Present Study ,
The studies reviewed demonstrate that a stress-induced increase in corticosterone, can 
impact hippocampal neurons and pathways (Sapolsky, 1991). The hippocampus is an 
important structure in encoding and processing of time-dependent associations and spatial 
memories (Zola-Morgan & Squire, 1993). Research has also shown that the 
administration of GCs can lead to deficits in spatial memory and hippocampal damage 
(Bodnoff et al., 1995, Quervin, Roozendaal & McGaugh, 1998, McLay, Freeman & 
Zadina, 1998). However, there are limitations to these studies.
The first limitation is that most of studies only measured differences in behavior once, 
after administration of a stressor or GCs. In addition, many of the studies also measured 
the effects of an acute stressor, while the long-term effects of a chronic exposure to stress 
have not been examined. McLay, Freeman and Zadina (1998) did administer GC for 80 
days, but then tested once, after treatment had been completed. This eliminates any
11
possible examination of effects at different times during treatment. Bodnoff et al. (1995) 
administered GC for 90 days and tested at one and three months of treatment; however, 
they only tested using the Morris water maze.
The present study examined the effect of corticosterone early and late in a 90-day 
period of treatment in order to assess short-term spatial memory (radial arm maze) and 
long-term spatial memory (water maze). Also, the present study incorporated the Kant 
(1993) water maze, a measurement of long-term memory, which has been shown to be 
sensitive to pharmacological interventions including amphetamine sulfate, diazepam, 
caffeine, and atropine sulfate.
The second limitation of previous work is that activity was not assessed in the 
corticosterone studies. High plasma levels of GC have bee’- ' ' m patients with
chronic depression (Sheline et al., 1996) and in patients with post-traumatic stress 
disorder (Bremner, 1999). In addition, high levels of GC have been associated with 
impaired performance on tests of memory in humans (Keenan et al., 1996). Animal 
models of depression have demonstrated decreased motor activity in an open-field test 
(Pare, 1994). Also, ZnD rats have exhibited impaired performance on open-field activity 
(Gordon, 1984). Therefore, activity level should be sensitive to manipulations of both 
GC and Zn. In the present study, 24-hour home cage activity and open-field activity 
using an apparatus which evaluates movements in 3-D was used to assess activity early 
and late in the treatment period.
The third limitation of previous work lies in the association of brain damage produced 
by GC and/or Zn with behavioral deficits. Only one study has been done (Bodnoff et al., 
1995) which examined behavior and direct effects of chronic CC treatment on
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hippocampal tissue. Hippocampal damage was not observed. However, several other 
studies have found damage to the hippocampus after exposure to GC (Sapolsky, 1991; 
Sapolsky, Krey & McEwen, 1985) but they did not measure behavior. In addition, 
Kawamoto and Halas (1984) found a correlation between ZnD and hippocampal 
damage. The present study examined two memory and two activity tests and associated 
performance to damage to hippocampal tissue due to GC and Zn.
The importance and uniqueness of the present study lies in the compounding of 
nutritional deficiency with environmental stress. Due to our fast-paced, technology based 
society with increasing stressful demands; important vitamins and minerals are consumed 
at unacceptably low levels. Instead, many modern diets consist of highly processed foods 
and decreased amounts of fruit ~»d whole grains. One of the symptoms of
depression and post-traumatic stress disorder is decreased appetite, which also may lead 
to decreased consumption of Zn. Zn may compound existing problems with stress and 
excess GC, resulting in greater amounts of hippocampal damage and indirect effects on 
memory.
The hypotheses of this study were that hippocampal degeneration as a result of long­
term GC exposure and ZnD would (1) result in decreased long- and short-term spatial 
memory in Sprague-Dawley rats with a greater decrease in memory in ZnD rats as 
compared to ZnA animals, and (2) degeneration of the dendrites and cell bodies of the 
hippocampus would be apparent in the CC treated animals with more degeneration 
exhibited in the ZnD rats than the ZnA animals and this would correspond to greater 
deficits found in memory (see Figure 1).
1—►  P o o r N u tritio n
I▼
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Figure 1. Diagrammatic model of the hypotheses of the present study.
CHAPTER 2
METHOD
Animals
Seventy-two male weanling Sprague-Dawley rats were ordered from SASCO 
(Wilmington, MA) and housed at the U.S.D.A. Human Nutrition Center (Grand Forks, 
ND) for five months before implementation of experimental treatments so that effects of 
the treatments could be examined in mature (6-month old) rats. During that first 5 
months, all animals were fed a control growth diet (AIN-93G; Reeves, Nielsen & Fahey, 
1993) containing 12 ppm Zn. At 6 months of age, the animals were randomly assigned to 
one of three experimental diets described below, all based on the AIN-93M diet (Reeves, 
Nielsen & Fahey, 1993), and remained on those diets for the duration of the study (13 
weeks). Both diets (AIN-93G and AIN-93M) were formulated to exceed nutrient 
requirements published by the National Research Council (1978) for laboratory rats. De­
mineralized water was available ad libitum. The rats were housed in individual metal 
cages under a 12-hour reversed light/dark cycle (0800-2000). The animal room was 
maintained at 22° C (+/- 2° C) and 45% (+/- 10%) relative humidity. The animals were 
matched for weight across treatment groups prior to the start of treatment. The NIH 
Guide for Care and Use of Animals was followed and the Animal Care and Use 
Committee approved the animal care protocol at the USDA-ARS Grand Forks Human 
Nutrition Research Center.
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Materials and Apparatus
All rats were assigned to one of three dietary groups, 24 rats were fed the AIN- 
93M diet containing an adequate concentration of 12 ppm Zn (ZnA), 24 rats were fed the 
AIN-93M diet containing low concentration 1 ppm Zn (ZnD), and 24 rats were fed the 
ZnA diet containing 12 ppm Zn but intakes were restricted to intakes of matched rats in 
the ZnD group (pair-fed; PF). Because of the known problem with weight loss associated 
with ZnD (Gordon, 1984), the pair-fed group provided a control group for food 
consumption. The rats were fasted by removing their food the evening prior to the radial 
arm and Tru-Scan activity testing. Again, de-mineralized water was available ad libitum. 
The food pellets used as motivation/reward in the radial arm maze and the Tru-Scan 
activity Monitor consisted of sucrose (Bioserve, Frenchtown >T T'
The CC treatment groups received sustained corticosterone exposure through 2 
subcutaneous implanted 200 mg-corticosterone pellets in the upper back (total dose 400 
mg) (Innovative Research, Sarasota, Florida), designed to release corticosterone at 4.44 
mg/day for 90 days. This dose was the same as used by Bodnoff et al. (1995). The 
control groups received a sham surgery. Any minor rise in CC levels as a result of the 
surgery was expected to diminish during the one-week recovery period and should not 
have affected behavioral testing or had permanent effects on hippocampal tissue. Plasma 
CC levels were determined monthly from 3 ml of blood taken from the tail and using a 
HPLC procedure described below. Behavioral testing utilized Coulbourn Instrument’s 
modular testing equipment. The 22-hour Home Cage Monitoring System included 
individual infrared sensors placed on each rat’s home cage. The sensors continually 
record small and large movements and the duration of movement for 22-hour blocks of
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time. The Tru-Scan Activity Monitoring Chamber consists of three sensor rings capable 
of tracking movement in X, Y, and Z planes. The chamber also has a 16-hole nose poke 
floor. The eight-arm radial maze (Olton & Samuelson, 1976) has three-feet long runways 
attached to a central hub controlled with guillotine doors that are computer controlled. 
Each entryway contains a photo-beam sensor as well as a pellet feeder trough at the end 
of each runway. The Kant (1993) water maze consists of a large water tank (5’diameter), 
painted white with non-toxic paint. White, opaque plastic walls, 50 cm high form a series 
of concentric squares with doorways in the center of the walls. Alleys between the walls 
are 16 cm wide. A movable, square platform extends above the water line, to provide an 
escape platform. The maze was filled to the height of 25 cm with 240 C water and this 
temperature was maintained throw1 j. ‘wty. A white curtain surrounds the maze 
and cue shapes are placed around the curtain. The maze was video taped and the tapes 
were analyzed for latency and number of errors. Boli were also collected in order to 
monitor the stress status of each rat. All behavioral testing equipment was wiped clean 
with a sanitizing solution between animals in order to reduce the possibility of odor cues.
Procedure and Sequence
Near the end of the 5-month growth period, the rats were handled once weekly by the 
experimenter in order to habituate the rats to handling. Experimental diets were 
introduced at 6-months during the week of CC pellet implantation. De-mineralized water 
was freely available to the rats in their home cage. According to Sapolsky (1995) and 
Mclay et al. (1998), when elevated CC concentrations are administered for one week or 
more, possible side effects include weight loss, opportunistic infections, and loss of 
calcium in the bones. ZnD has also been found to cause anorexia in rats. Due to these
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concerns, food consumption and weight loss were monitored. The animals were weighed 
every Wednesday during the study by vivarium staff. Daily food consumption was 
assessed by vivarium staff on a daily basis and pair feeding was done until it was 
determined that pair-feeding was unnecessary due to little difference in weight or food 
consumption between the dietary groups. Pair-feeding was ended on the same day for 
both groups, resulting in the end of pair feeding at two months for group A and at 6 
weeks for group B. Food consumption was done 5 days a week at this time until the end 
of the study. Both CC exposure and ZnD may also increase the opportunity for illness 
due to decreased immune function. Every attempt was made to reduce the possibility of 
illness through cooperation with veterinarian and vivarium staff and the use of universal 
preca’v' \ 'T1 •, schedule for the study is included in Appendix A. All behavioral tasks, 
surgical procedures, blood draws, necropsy and perfusion procedures were practiced 
using five scrub animals prior to experimentation.
Behavioral Task Training
During the first two weeks of the study, the animals received training on the radial- 
arm maze and the water maze. For the radial-arm maze, in the first two days of training, 
sucrose pellets were scattered throughout the eight arms (three pellets per arm) and the 
fasted rats (fasted since 10:00 P.M. the night prior to training) were allowed 15 min to 
explore the arms. For the last three days, the ends of all eight arms were baited once, and 
the fasted rats were allowed to freely move in the maze for 15 min (Handelemann & 
Olton, 1981). Water maze training occurred during week two. Each animal was allowed 
to swim from the center starting point in the maze until it reached the finish platform 
placed in the outer rim of the maze or five min had elapsed. Those animals that did not
18
reach the platform in five min were pushed gently with a paddle through the maze to the 
finish platform. All animals received three trials each day with 30 s between trials. The 
animals were trained for five consecutive days or until they reached criterion. Those 
animals that successfully reached the platform in two consecutive trials within 100 s were 
considered trained. Animals were counterbalanced across training conditions in that half 
of the animals from each group received radial-arm maze training and then water maze 
training during week two. The other half of the animals received the reverse order of 
training.
Corticosterone Administration and Monitoring 
After training, corticosterone pellets were implanted in six rats per day for a total of 
twelve days. The animals were assigned implantation numbers matched across groups 
with animals 1-6 implanted on day one, animals 7-12 on day two, through animals 67 - 
72 on day twelve. The animals were anesthetized with an isoflurane (4%) and oxygen 
mixture by using an ANESCO anesthesia machine and Ohio vaporizer (chamber induced 
and nose cone maintained). Once the animal was anesthetized, the animal’s upper back 
between the shoulder blades was shaved with an electric trimmer. The shaved area was 
then wiped twice with Betadine to prevent infection. To implant the pellets, the shaved 
area was wiped with an alcohol wipe to get rid of any dirt. The animal’s level of 
anesthesia was then checked by pinching the animal’s foot and ears. If there was no 
reaction, surgery began. If there was a reaction, the level of anesthesia was slightly 
increased. The skin on the upper back of the animal was pinched to separate it from the 
underlying muscle and a small incision was made with dissecting scissors. A pocket on 
each side of the spinal cord was then made with blunt edge scissors and two pellets were
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implanted on each side. The edges of the animals skin was then gathered up and stapled 
shut with wound clips. Any blood was cleaned up using a gauze pad. Sham animals 
received the same incision and the wound was stapled shut without any pellets implanted. 
Blood was drawn from the tail in order to measure baseline corticosterone concentrations 
in all animals. The animal’s tail was dipped in warm water to dilate the blood vessels in 
the tail. The animal was then placed back on the table dorsal side up, with its nose in the 
anesthesia machine nose cone. The animals body was placed in a straight line and the 
index finger of the experimenter’s left hand pressed down hard on the animal’s tail to 
stop the flow of blood, and expose the vein. The tail vein appears as a white-pink line 
running down the middle of the tail. The 3-ml syringe with a 22-gauge needle was 
inserted at a 45-degree angle in the area of the tail vein in order tr • ’ a +ail artery,
which is directly below the vein. When the tail artery is reached, blood began filling the 
syringe and when possible 3-ml of blood was collected. The blood was then placed in 5- 
ml falcon tubes containing EDTA, an anti-coagulant. The tube was closed and carefully 
mixed. All blood samples were centrifuged for 15 minutes at 3000 rpm, plasma separated 
and then kept in a -809C Revco freezer. The animals were then kept warm after surgery 
and monitored until they awakened. The animals were allowed to recover from the 
operation for one week. Corticosterone concentrations in plasma was measured once 
every four weeks during the study for a total of three times, following the same order as 
implantation to provide consistent CC exposure for all animals.
Behavior Testing Sequence
All animals followed the same treatment and testing sequence, but, for logistical 
reasons they were run in two groups staggered one week apart. Animals were tested for
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the first session of 22-hour home cage monitoring during week 2, session one of the 
radial-arm maze during week 3, session one of the water maze during week 5, the Tru- 
Scan Activity monitoring during week 9. the second session of the 22-hour home cage 
monitoring during week 10, the second session of the radial-arm maze during week 11 
and the second session of water maze during week 12. All behavioral testing (with the 
exception of 22-hour activity testing) occurred in the same order as the implantation 
schedule with six animals per day in order to provide consistent CC exposure for all 
animals. Animals were tested between 9:00 A.M. and 1:00 P.M. (except for 22-hour 
activity testing) in order to control for any effects of time-of-day. During the breaks in the 
behavioral testing sequence the animals were left in their home cage. The tests were 
distributed throughout the study to n"' ~ 'Tly examine the chronic versus acute
effects of CC exposure.
The 22-Hour home cage monitoring system was set to provide continuous monitoring 
of activity for two complete days. Eighteen rats were monitored at one time. The entry 
of laboratory technicians for feeding and health monitoring into the room in which the 
rats were housed was indicated on a log.
Tru-Scan activity monitoring sessions were 60-min long in which the fasted rats 
(fasted since 10:00 P.M. night before testing) were measured for latency and errors in 
collecting sucrose pellets placed in the 16-hole floor during the first 30 minutes of the 
session. During the second half of the session, a 1500-Hz tone was sounded at 30, 40 and 
50 min for 20 seconds. The computer measured many variables of activity, rearing, and 
nose-poke.
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For the water maze testing, the animals were placed in the same starting area as the 
training sessions and allowed five min to find the exit platform. The animals were tested 
for three trials each with a 30 s rest period between each trial.
For the radial-arm maze, the fasted animals were placed in the center box of the eight- 
arm radial maze with all of the guillotine doors closed. After 30 s, all eight doors opened 
at once. After the rat had traveled to the end to the end of an arm, received the reinforcer, 
one sucrose pellet and the animal had returned to the starting area; all eight doors were 
again closed followed by a 10 s delay. Then all eight doors were again opened and the 
animal was allowed to choose among all eight arms, including those that had already 
been visited. This sequence continued until the animal had visited all eight arms and 
received ~ >. filet or 15 min have elapsed. The animals received three test trials
separated by one hour between each trial during which the animal was returned to its 
home cage.
Necropsy, Perfusion and Examination of Hippocampal Tissue 
Necropsy and perfusion occurred following the same six rats per day schedule with 
half of the rats each day euthanized at the Grand Forks Human Nutrition Research Center 
(A.M.) and half of the rats perfused at the UND Anatomy and Cell Biology Department 
(P.M.). The animals were divided between the two locations according to the condition 
of the implanted pellets throughout the study. Several animals’ pellets became exposed 
and had to be re-implanted on one or more occasions. Those animals that had no repair 
surgery or only minor surgeries were classified as “perfect”, only one repair surgery was 
classified as “less than perfect” and those animals with multiple repair surgeries were 
classified as “bad” (see Table 1). This was done in order to maximize the potential for
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animals with good corticosterone pellet implantations to be evenly distributed at both 
sites.
Table 1. Division of Animals between Necropsy and Perfusion
Zinc- Adequate Diet
CC (Perfect) CC(LP) CC (Bad) Total CC Sham-surgery
Necropsy 2 3 6 11 13
Perfusion 5 2 5 12 10
Zinc -Deprived Diet
CC (Perfect) CC(LP) CC (Bad) Total CC Sham-surgery
Necropsy 2 2 2 6 6
Perfusion 4 0 2 6 6
Note. P= perfect, defined as no repair surgeries or only 1 minor surgery 
LP= less than perfect, only 1 repair surgery 
B= bad, multiple repair surgeries
For the necropsy at the Nutrition Center, animals were deeply anesthetized with a 
euthanizing dose of Ketamine and Rhompin. Ten ml of blood was then collected through 
a heart puncture and placed in a 10 ml tube containing EDTA. Two ml of this blood was 
used for cell count analysis using a Cell-Dyne apparatus (Abbott Laboratories, Illinois). 
The remaining eight ml of blood was separated and 1.5 ml of the plasma was frozen for 
corticosterone concentration measurement. The remaining plasma was also frozen and 
sent to the Trace Mineral Lab at the Grand Forks Human Nutrition Lab for analysis of 
concentration of trace minerals. The animals were then decapitated and the brain, liver 
and femurs were removed, weighed and frozen for trace mineral analysis. The trace 
mineral analysis of the blood, brain, liver and femurs was unavailable for this paper. The
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brains were cut in half through the corpus callosum and 1/2 was retained for total brain 
mineral concentrations. The other 1/2 was sent to Neurobiotex (Galveston, TX) for 
analysis of brain-zinc-vesicle concentration.
For those animals selected for perfusion, they were brought over to the Anatomy 
Department on the day of perfusion. The animals were deeply anesthetized with an 
euthanizing dose of sodium pentobarbital. The animal’s chest cavity was opened and 
prior to perfusion, 2-3 ml of blood was collected through the right atrium from an 
exposed heart. This blood was placed in a 5ml tube containing EDTA. This blood was 
separated and 1.5 ml of the plasma was frozen and used for analysis of corticosterone 
concentrations. The remaining plasma was sent to the Trace Mineral Lab at the Grand 
Forks Human Nutrition Center for analysis of trace mineral concen* ' ’ve animals 
were then injected with a prefix solution containing 1000 gl/ml heparin and 1% sodium 
nitrite with a 22-gauge needle placed in the left ventricle of the heart. The animals were 
perfused for about 10 minutes at a rate of 10-15 mls/min with 4% paraformaldehyde with 
a total of 200 ml of fixative perfused per animal. The brains were then removed and 
placed in 4% formaldehyde for one hour as a secondary fixative. They were then 
transferred to a 15% sucrose/formalin solution for cryoprotection and placed in a 
refrigerator.
Histological examination of the hippocampus was done at the University of North 
Dakota Anatomy and Cell Biology Department. Twelve animals were selected for 
analysis with three animals per dietary group (zinc-adequate and zinc-deprived) and three 
animals per treatment group (corticosterone implant and sham surgery). The 
corticosterone implanted animals were those that were classified as either “perfect” or
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“less than perfect” in order to reduce any noise from multiple implant surgeries. These 
twelve brains were each sliced in half with the left half of the brain used for analysis.
The right half of the brain was returned to the refrigerator to be used at a later date. The 
left half of the brain was placed on a sliding, freezing microtome and 40 pm slices were 
made through the entire thickness of the brain. These slices were placed in a potassium 
buffered solution (PBS) (80% double-distilled water :20% phosphate buffer). Fifteen 
slices from each animal was then mounted on gelatinized slides and allowed to dry.
These slices were then rinsed in the PBS solution, stained with a toulidine blue stain for 
30 seconds and then the excess staining solution was rinsed off with PBS. After the slides 
dried, they were coverslipped with a 1:1 glycerol solution.
Examination of the zinc-concentrati  ^ :1 Neurobiotex (Galveston, Texas)
using the 6-methoxy 8-p-toluene sulfonamide quinoline (TSQ) fluorescence method for 
staining zinc in brain zinc vesicles (Frederickson, Kasarskis, Ringo & Frederickson, 
1987).
Determination of Plasma Corticosterone Concentrations 
The measurement of plasma concentrations of corticosterone was done following 
a high-performance liquid chromatography procedure as outlined in a paper by Dawson, 
Kontur and Mojan (1984). Standards for the HPLC including corticosterone, 11- 
deoxycorticosterone, hydrocorticosterone (cortisol), cortisone and cortisone acetate were 
purchased from Sigma-Aldrich Chemical Co. (St. Louis, Mo). Standards were made up 
in mobile phase as stock solutions (250 pg/ml) and stored at 09C. The mobile phase 
consisted of 77.5% 18 meg ohm (ultra-pure) water, 12% tetrahydrofuran and 10.5% 
acetonitrile. The mobile phase was flask filtered using a 45 pm Nylaflo nylon membrane
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filter. This mobile phase was delivered using a Shimadzu LC-10AD pump module and 
was set at a flow rate of 2 ml/min during detection. Separation occurred on a 4.5 X 250 
mm Supelcosil LC-8 5 analytical column which was protected by a 4.6 X 50 mm LC-8 
Pelliguard column. Both columns were purchased from the Supelco division of Sigma- 
Aldrich (St. Louis, MO). Column temperature was maintained at 50PC by a Shimadzu 
CTO-IOAC column oven. Samples were auto injected using a Shimadzu SIL-10A auto­
injector. Detection occurred using a Shimadzu variable wavelength UV-VIS detector set 
a 239 nm. All HPLC modules were controlled using a Shimadzu SCL-10A system 
controller. Data was integrated and recorded using a Shimadzu CR-501 Chromatopac. 
Peak height and internal standardization was used for quantification. Standard calibration 
curves wer > c " /.
All blood samples were centrifuged for 15 min at 3000 rpm, plasma separated and 
then kept in a -80PC Revco freezer. On the day each sample was processed it was 
removed from the freezer, kept on ice and thawed for 1 hr. Approximately 20 samples 
were processed each day. First, each sample was vortexed for 5 s in order to thoroughly 
mix the plasma. One ml of plasma was then pipetted into a 3-ml glass tube and 2-ml of 
the internal standard consisting of 100% methanol containing 100 ng of dexamethasone 
was added to each tube. This mixture was then vortexed for 30 s which served to 
deproteinate the plasma and extract protein-bound and free steroids. The mixture was 
then placed in a refrigerated centrifuge for 5 min at 3000 rpm and low brake. After 
spinning down, the supernatant that has been separated out was poured into another 3-ml 
glass tube, which contained 2-ml of 18 meg ohm water and vortexed for 5 s to mix 
thoroughly. This solution was poured into separate 3-ml C-18 extraction columns using a
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vacuum manifold. The samples were then washed with 2 washes of 1.0-ml volume of 18 
meg ohm water, followed by 1 wash of 1.0-ml of 10% methanol solution, and then 2 
washes of 1.0-ml of 20% acetone solution. The samples were then eluted into 1.5-ml epi 
tubes with two washes of .5 ml 100% methanol and then dehydrated in a Supervac for 
approximately 3 hours or until thoroughly dry. During this period the C-l 8 columns 
were regenerated for the next day’s use by doing 3 washes of 3-ml each of 100% 
methanol. When the samples were dry they were then reconstituted with 100 pi of 100% 
methanol and syringe filtered into 100 pi HPLC vials with screw tops and seals and 
placed into the HPLC apparatus to be auto-injected into the column. Standards were 
injected and analyzed first each day followed by one 20 pi injection of each sample.
CHAPTER 3
RESULTS
This study incorporated a 3 (diet) X 2 (treatment) X 2 (time) mixed factor design with 
one within-subjects factor and two between-subjects factors. The between-subjects 
factors were zinc and corticosterone while the within factor was time. The dependent 
variables for this design were 22-hour activity monitoring (two sessions), water-maze 
testing (two sessions), radial-arm maze (two sessions), Tru-Scan activity monitoring, 
serum corticosterone levels (baseline and three testings), cell count of*1 ' ” mpal
S
cells and width of pyramidal cell layer of the CA1 and CA3 areas of the hippocampus, 
the calculation of zinc concentration in vesicles in the hilus, CA1, CA3 areas of the 
hippocampus, the cortex and thalamus, total weight and food consumption, whole blood 
cell count and trace mineral analysis of plasma, brain, liver and femurs. Analysis was run 
separately for each variable and are presented below, starting with the physiological 
measurements, followed by the behavioral measures and then an overall correlational 
analysis comparing blood and brain values with results from behavioral testing. In 
instances of the violation of the assumption of sphericity for ANOVAs, the Greenhouse- 
Geisser corrected ANOVA was used and reported. In all occasions when a significant 
effect was found regardless of correction method, the Greenhouse-Geisser was not used 
and is not reported in this paper.
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Corticosterone Concentrations
Tlr
HPL 
time is the a 
detected. 
Concentratid) 
standard for 
this regressib:
C samples were matched with standards using retention times. Retention 
mount of time the sample is exposed to the UV wavelength before a peak is 
ose samples which did not match standard retention times were discarded, 
ns were determined by running a linear regression on three levels of each 
each day of the experiment and the constant and x coefficient derived from 
n used to compute concentrations (pM) using the following formula:
Plasma concentration = (area of peak of sample -  constant) / x coefficient.
Table 2. Me an Corticosterone Concentration: Time X Treatment
Treatment = Corticosterone Implant
Dietary Condition
____________ ' u
Zinc-adequate Zinc-deprived
Baseline 17.29 18.56
(6.66) (2.64)
One Month 13.21 14.47
(6.27) (3.10)
Two Months 13.43 14.18
(5.93) (2.20)
Three Months 16.95 13.76
(10.75) (3.95)
Treatment = Sham Surgery
Dietary Condition
Zinc-adequate Zinc-deprived
Baseline 16.47 17.12
(3.22) (3.83)
One Month 14.68 15.79
(3.05) (1.90)
Two Months 14.41 16.25
(3.69) (2.59)
Three Months 20.86 18.97
(3.51) (4.33)
Note. Parentheses indicate standard deviation. Concentrations are in pM.
The only 
other steroid 
low sample 
not presented 
table 2.
Table 3. Sou:
steroid which demonstrated significant differences was corticosterone. The 
measurements resulted in few determined concentrations, resulting in a very 
^ize making analysis difficult on these measurements. The other steroids are 
here. Means and standard deviations for corticosterone can be found in
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rce Table for Corticosterone Concentration
Source SS df MS Prob. Power Eta
Time 133.83 44.61 11.37 .00* 1.00 .45
Time X Treatment 62.20 20.73 5.28 .00* .91 .27
Time X Diet 39.32 13.11 3.34 ,03H .72 .19
Time X Treatment 2.53 
X Diet
.85 .22 .89 .09 .02
Error 1 0 - + . 8 I 42 3.92
Note. * = p <05.
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Figure 2. Time of Corticosterone Draw.
Measurements were taken at baseline, one month, two months and at 
necropsy/perfusion at three months.
ment) X 2 (Diet) X 4 (Time) mixed ANOVA resulted in a main within- 
ct of Time with F (3, 42) = 11.37, p < .01 (see Table 3). Higher mean values
atwere found 
(M= 14.54 
A signify 
.003 was 
revealed tha: 
baseline (M 
draws (one
Baseline (M=17.36 pM) and Three months (M=17.64 pM) than at Month 1 
I^M) and Month 2 (M= 14.57 pM) draws (see Figure 2). 
ant within-subjects interaction of Time X Treatment, F (3,42) = 5.28, p = 
found (see Figure 3). A subsequent analysis using t-tests (2-tailed) 
for the corticosterone-implant group the highest concentration was found at 
= 17.92 pM) with this draw significantly higher than all three of the other 
month M = 13.84 pM; two months M = 13.81 pM; and three months M =
also
15.36 pM).
month draw
three of the other draws (baseline M = 16.79 pM ; one month M = 15.23 pM; and two
uonths M =
3 0
For the sham surgery group the highest concentration was found at the three- 
(M = 19.91 pM) with this draw significantly higher concentration than all
15.33 pM).
o 25 
S
S 20oco
* 15co
B  10
(AOu
t  5o 0 O
S o s
Baseline Month One Month Two 
□  Implant ■  Sham-Surgery
Month Three
'igure 3. Time X Treatment for Corticosterone Concentrations.
Measurements were taken at baseline, one month, two months and 
at necropsy/perfusion at three months.
A significant within-subjects interaction of Time X Diet was found, F (3,42) = 3.34 p= 
.028 (see fidure 4). A subsequent analysis using t-tests (2-tailed) of this interaction
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revealed that for the zinc-adequate animals the highest corticosterone concentration was 
at 3 months (M = 18.90 pM) and a there was a significant difference between this draw 
and all three; of the other measurements (baseline M = 16.88 pM; one month M = 13.94
pM and two 
concentratioi 
different fro 
no significant 
animals also 
pM) than 
diet groups
the
months M = 13.92 pM). For the Zinc-deprived animals the highest 
n was found at baseline (M = 17.84 pM) with this draw significantly 
m the one month (M = 15.13 pM) and two month draws (M = 15.22 pM) and 
difference between month three and the other draws. The zinc-adequate 
had a significantly higher concentration at the three month draw (M = 18.90 
Zinc-deprived animals (M = 16.37 pM) with no other differences between 
'or the baseline, one month and two month draws.
Baseline Month One Month Two Month Three 
□  Zinc-Deprived ■Zinc-Adequate
In o
Figure 4. Time X Diet for Corticosterone Concentrations.
Measurements were taken at baseline, one month, two months and 
at necropsy/perfusion at three months.
rder to determine if the location of the last blood draw played a factor in this
analysis an independent samples t-test was used to compare the three month blood draw 
for the animals which had been perfused at the Anatomy and Cell Biology Laboratory
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with those animals which underwent necropsy at the Nutrition Center. This test was 
important because half of the animals were sampled in the morning during the necropsy 
at the Nutrition Center and the other half were sampled in the afternoon during the 
perfusions at the Anatomy and Cell Biology department. This difference in sample times 
could potentially lead to confounding effects of time of day as corticosterone levels 
fluctuate throughout the 24-hour cycle with the lowest level found in the afternoon on a 
reversed light-dark cycle. Another potentially confounding effect may be differences in 
environmental setting as levels of stress hormones are extremely susceptible to 
environmental stressors. The T-test was not significant, t (51) = -1.391, p = .170 (2-
tailed). In addition, those animals which had received more than one reimplantation
surgery during the study were compared tnimals which did not require
implantation. A t-test resulted in no significant differences between these two groups for 
all 4 measurements of corticosterone, baseline: t (10)= .58, g = .58 (2-tailed), one month: 
t (24)= -.86 g = .40 (2-tailed), two months: t (25) = -.518, g = .61 (2-tailed) and three 
months: t (26) = -1.77, g = .09 (2-tailed). Thus multiple re-implantations did not have a 
significant effect on corticosterone concentration.
Weekly Weights and Food Consumption 
Average weight for each animal for the entire treatment period and average food 
consumed was determined and used for group analysis. A 2 (Treatment; Corticosterone- 
implant, Sham-surgery) X 3 (Diet; Zinc-adequate, Zinc-deprived, Pair-fed) ANOVA 
resulted in Significant differences for average weight for treatment group, F (1,65) =
12.94, g = .001 and for average food consumption for treatment group, F (1,65)= 5.28, g 
= .03. The qorticosterone implant group was significantly heavier (M= 537.86g) and
consumed rrtore food (M= 21.98g) than the sham surgery group (weight M=508.71g; 
food M= 21 J22g). There were no significant differences for dietary group or for the 
interaction of treatment and dietary group.
Table 4. Mean Weight: Treatment X Diet
3 3
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequate 537.38
(40.47)
511.45
(29.83)
Zinc-deprived 539.80
(35.34)
503.23
(28.77)
Note. Parentheses indicate standard deviation. Weights are listed in grams.
Table 5. Soiree Tnb,<a for Mean Weight
Source df MS Prob. Power Eta
Treatment 15517.34 1 15517.34 13.11 .00* .95 .16
Diet 133.88 133.88 .11 .74 .06 .00
Treatment X Diet 449.43 449.43 .38 .54 .09 .01
Error 79333.74 67 1184.09
Note. *= p 
With the 
(Diet) ANO 
average we 
.009. In this 
consumed m 
food M = 21 
interaction
<.01.
pair-fed animals collapsed into the zinc-adequate groups, a 2(Treatment) X 2 
VA also resulted in a significant differences for the Treatment group for 
ight, F (1,67) = 13.11, p = .001 and for food consumption F(l,67)= 7.27, p = 
analysis the corticosterone implant group weighed more (M= 538.59g) and 
ore food (M= 22.13g) than the sham surgery group (weight M = 507.34g; 
.20g). There were no significant differences for dietary group or the 
tween dietary group and treatment. Means and standard deviations for thisbe
second anal] 
consumptior
Table 6. Me
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rsis are presented in Tables 4 and 5 (weight) and tables 6 and 7 (food 
0-
in Daily Food Consumption: Treatment X Diet
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequ<ite 21.69 21.28 
(1.34) (1.16)
Zinc-deprive:d 22.57 21.11 
(1.88) (1.28)
Note. Paren 
Table 7. Sou
theses indicate standard deviation. Consumption is listed in grams, 
rce Table for Daily Food Consumption
' ’irce SS df MS F Prob. Power Eta2
Treatment 13.84 1 13.84 7.27 .01 .76 .10
Diet 2.06 1 2.06 1.08 .30 .18 .02
Treatment X Diet 4.37 1 4.37 2.30 .13 .32 .03
Error 127.60 67 1.91
Note. *= p <
A 2(Treat 
in several sij 
corticosteror 
surgery anirr 
significantly
:.01.
Necropsy Organ Weights and Hematology 
ment) X 2(Diet) ANOVA on the necropsy body and organ weights resulted 
;nificant differences for treatment. The total body weight for the 
e-implant animals (M = 555.46g) was significantly greater than the sham 
als (M = 524.07g), F (1, 32) = 4.77, p = .04. Liver weight was also 
greater in the corticosterone treated animals (M = 16.08g) than sham-
3 5
surgery aninlials (M = 14.16g), F (1, 32) = 6.57, 2 = -02. (see Tables 8 and 9) No 
significant effects of diet or interactions between treatment and diet were found.
Table 8. Me m Necropsy Animal and Organ Weights: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-Adequate Zinc-deprived Zinc-Adequate Zinc-deprived
Body Weight 569.84
(40.64)
541.08
(43.93)
535.35
(37.52)
512.79
(48.85)
Brain Weight 2.38
(.09)
2.33
(.17)
2.28
(.09)
2.27
( .12)
Liver Weight 16.05
(2.43)
16.12
(2.34)
14.91
(2.34)
13.41
(1.16)
Note. Parentheses indicate standard deviation. Weights are listed in grams. 
Table 9. Source Table for Necropsy Animal and Organ Weights
Source SS df MS F Prob. Power Etaz
Treatment Weight 8428.46 1 8428.46 4.77 .04* .56 .13
Brain .05 1 .05 4.09 .05 .50 .11
Jver 31.80 1 31.80 6.57 .02* .70 .17
Diet Weight 5632.54 1 5632.54 3.19 .08 .41 .09
3rain .01 1 .01 .62 .44 .12 .02
Jver 4.36 1 4.36 .90 .35 .15 .03
Treatment Weight 82.14 1 82.14 .05 .83 .06 .00
X Diet Brain .01 1 .01 .48 .50 .10 .02
Jver 5.21 1 5.21 1.08 .31 .17 .03
Error Weight 56494.95 32 1765.47
Brain .41 32 .01
Jver 154.92 32 4.84
Note. * = p |<.05.
Completd blood count was assessed to ascertain the health of the animals at the end of 
the study. Sapolsky (1995) and McLay et al. (1998) found side effects of corticosterone 
administration including opportunistic infections. In addition, zinc-deprivation has been
associated vKth depressed immune system function. Complete blood cell count includes 
measurements of white blood cells which can indicate whether the immune system has 
been activated in the presence of virus, bacteria or allergens. The complete blood count 
(CBC) was measured by a Cell-Dyne apparatus (Abbot Laboratories, Illinois) and
ts included red blood cell count, hemoglobin, hematocrit, mean cell volume 
n cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC), 
distribution width (RDW), platelet count and mean platelet volume (MPV). 
es listed in the tables are from Veterinary Hematology (Schalm & Jain,
measuremer 
(MCV), me| 
red blood a 
Normal valui
dll
1986).
Table 10. Mean Whole Blood Cell Counts: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery Normal
Zinc-Adequate Zinc-deprived Zn. Jnc-deprived
RBC 7.99 7.55 7.98 7.07 8.20
(-43) (.24) (.41) (.52) (.56)
Hemoglobin 13.61 13.88 13.38 12.40 15.00
(.97) (.22) (.80) (1.40) (.90)
Hematocrit 41.61 41.34 41.26 37.30 Not
(2.56) (1.20) (2.60) (3.94) Available
MCV 52.03 54.82 51.62 52.63 57.60
(1.89) (.95) (3.08) (1.77) (3.40)
MCH 17.06 18.40 16.78 17.50 18.30
(1.00) (.49) (.47) (.69) (1.1)
MCHC 32.80 33.58 32.34 33.23 31.90
(1.24) (.58) (1.39) (.21) (1.20)
RDW 15.40 14.78 15.10 15.47 Not
(1.11) (.62) (.79) (142) Available
Platelet 840.29 798.80 699.60 886.67 1,108.00
(227.66) (146.99) (203.54) (294.25) (193.00)
MPV 5.98 6.18 6.73 5.91 Not
(.76) (.36) (-33) (.30) Available
Note. Parentheses indicate standard deviation.
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An abnormal concentration of red blood cells and hemoglobin may be indicative of an
impairment 
anemia (see 
blood cells i 
than the Zin:
in the oxygen and waste carrying capacity of the blood or an animal with 
table 10). Red blood cell count (RBC), a measure of the number of red 
m the sample, was significantly greater in zinc-adequate animals (M = 7.99) 
deprived animals (M = 7.31), F (1,16) = 12.87, p = .00.
Table 11. Source Table for Whole Blood Cell Counts
Source /■ SS df MS F Prob. Power Eta2
Treatment RBC .27 1 .27 1.69 .21 .23 .10
-lemoglobin 3.35 1 3.35 4.38 .05 .50 .22
-lematocrit 22.04 1 22.04 3.42 .08 .41 .18
VICV 7.69 1 7.69 1.78 .20 .24 .10
VICH 1.58 1 1.58 2.89 .11 .36 .15
MCHC .74 1 .74 .65 .43 .12 .04
IDW .17 1 .17 .18 .68 .07 .01
Dlatelet 3184.07 1 3184.07 .07 .80 .06 .00
MPV <*> f 1 .27 .94 .35 .15 .06
Diet hBC 1 2.08 12.87 .00* .92 .45
hemoglobin .58 1 .58 .76 .40 .13 .05
-lematocrit 20.46 1 20.46 3.18 .09 .39 .17
VICV 16.52 1 16.52 3.82 .07 .45 .19
VICH 4.86 1 4.86 8.89 .01* .80 .36
VlCHC 3.20 1 3.20 2.78 .12 .35 .15
IDW .07 1 .07 .08 .79 .06 .01
3latelet 24188.59 1 24188.59 .53 .48 .11 .03
MPV .44 1 .44 1.52 .24 .21 .09
Treatment IBC .24 1 .24 1.49 .24 .21 .09
X Diet hemoglobin 1.77 1 1.77 2.31 .15 .30 .13
hematocrit 15.50 1 15.04 2.41 .14 .31 .13
VICV 3.61 1 3.61 .83 .38 .14 .05
VICH .44 1 .44 .81 .38 .14 .05
MCHC .01 1 .01 .01 .91 .05 .00
RDW 1.11 1 1.11 1.15 .30 .17 .07
5latelet 59617.39 1 59617.39 1.30 .27 .19 .08
MPV 1.18 1 1.18 4.12 .06 .48 .21
Error hBC 2.58 16 .16
hemoglobin 12.25 16 .77
hematocrit 103.07 16 6.44
MCV 69.20 16 4.33
MCH 8.75 16 .55
MCHC 18.39 16 1.15
RDW 15.46 16 .97
3latelet 736292.10 16 46018.26
MPV 4.60 16 .29
Note. * p <.03.
3 8
Mean cel 
hemoglobin 
deprived ani 
8.89, p = .01 
To compel 
values plus/: 
this study, 
at least one 
was at least 
(M = 13.61)
For
■'ry, zmc
ed
Zinc
Zinc-deprivi 
zinc-adequat 
surgery,
For MCH 
below norm; 
two SD beld' 
implant, Zinc 
33.23 were
For plate 
(M = 798. 
below the n<
80)
hemoglobin (MCH), an measurement of the average concentration of 
in the sample of red blood cells, was significantly greater in the Zinc- 
mals (M = 17.95) than in the zinc-adequate animals (M = 16.92), F (1, 16) =
. (see table 11).
re the whole blood cell counts with the normal values, the mean normal 
minus the standard deviation was compared against the counts obtained in 
red blood cell count, the implant. Zinc-deprived animals (M = 7.55) was 
SD below normal and the sham-surgery, Zinc-deprived animals (M = 7.07) 
two SD below normal. For hemoglobin, the implant, zinc-adequate animals 
and the implant, Zinc-deprived animals (M = 13.88) along with the sham- 
-adequate animals were at least one SD below normal. The sham-surgery, 
animals (M = 12.40) were two SD below normal. For MCV the implant,
:e (M = 52.03), sham-surgery, zinc-adequate (M = 51.62) and the sham- 
-deprived (M = 52.63) animals were at least one SD below the mean.
, the implant, zinc-adequate (M = 17.06) animals were at least one SD 
al whereas the sham-surgery, zinc-adequate (M =16.78) animals were at least 
w the normal mean. For MCHC the implant, zinc-adequate (M = 32.80), 
-deprived (M = 33.58) and the sham-surgery, Zinc-deprived animals (M = 
least one SD above the normal mean.at
et count the implant, zinc-adequate (M = 840.29), the implant, Zinc-deprived 
and the sham-surgery, Zinc-deprived (M = 886.67) were at least one SD 
ormal mean. The sham-surgery, zinc-adequate (M = 699.60) were at least
two SD below the normal mean.
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The Cell-Dyne machine measured not only total white blood cell count, but also the 
percentage cjf several types of white blood cells; neutrophils, lymphocytes, monocytes, 
eosinophils and basophils. Normal values are from Veterinary Hematology (Schalm & 
Jain, 1986) (see table 12).
Table 12. M^an White Blood Cell Counts: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery Normal
Zinc-Adequate Zinc-deprived Zinc-Adequate Zinc-deprived
White Blood 
Cell Count
3.62
(1.69)
4.79
(1.49)
5.66
(2.28)
2.99
(2 .01)
Not
Available
Neutrophil % 33.86
(8.84)
29.66
(10.76)
11.39
(2.43)
23.65
(10.87)
25.36
(7.50)
Lymphocyte % 52.11
(12.28)
58.34
(16.33)
80.43
(3.20)
56.48
( 11.22)
70.60
( 8.0)
Monocyte % 11.86
(6.48)
10.23
(6.31)
7.05
(2.51)
16.33
(9.63)
2.30 
(1 8r
Eosinophil % 1.26
(.49)
1.06
(.60)
.63
(.51)
2.06
(145)
1.60
( 1.2)
Basophil % 1.01
( 1 . 1 1 )
.70
(.80)
.49
( . 20)
1.53
( 1.10)
.10
(.31)
Note. Parentheses indicate standard deviation
significant effects for treatment were found. For total white blood cell count a 
Treatment X Diet interaction was found, F(l, 18) = 5.82, p = .03. Subsequent 
ealed that the sham-surgery, zinc-adequate animals (M= 5.66) had 
more white blood cells than the sham-surgery, Zinc-deprived animals (M = 
e corticosterone-implant, zinc-adequate animals (M = 3.62) with no 
r the corticosterone-implant. Zinc-deprived animals.
ercentage of lymphocytes, there was a significant effect of treatment F (1, 18) 
03 with a significantly greater percentage in the sham surgery animals (M = 
in the corticosterone implanted animals (M= 55.23). A significant Treatment 
ction was also found, F (1, 18) = 7.16, p = .015. For the sham-surgery
Several 
significant 
analysis revi 
significantly 
2.99), and 
difference 
For the p 
= 5.50, p = . 
68.45) than 
X Diet interhi
thi
fo
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mon
animals the 
adequate an 
also had 
and cortico 
antibodies 
Table 13.
Zinc-deprived animals (M= 56.48) had less lymphocytes than the zinc- 
mals (M = 80.43). The sham-surgery, zinc-adequate animals (M = 80.43) 
e lymphocytes than the corticosterone-implanted, zinc-adequate (M = 52.11) 
starone-implant, Zinc-deprived animals (M = 58.34). Lymphocytes produce 
against foreign materials such as viruses and bacteria, 
urce Table for White Blood Cell Counts.So
Source SS df MS F Prob. Power Eta2
Treatment Total .07 1 .07 .02 .89 .05 .00
Neutrophil 1031.91 1 1031.91 12.09 .00* .91 .40
Lymphocyte 889.92 1 889.92 5.50 .03* .60 .23
Monocyte 2.13 1 2.13 .05 .83 .06 .00
Eosinophil .18 I .18 .30 .59 .08 .02
Basophil .11 1 .11 .14 .72 .06 .01
Diet rotal 2.91 1 2.91 .90 .36 .15 .05
Neutrophil 82.68 1 82.68 .97 .34 .15 .05
Lymphocyte 399.70 1 399.70 •M7 '.3 .32 .12
Monocyte 74.59 1 74.59 .24 .09
Eosinophil 1.90 1 1.90 _ .40 .15
Basophil .67 1 .67 .81 .38 .14 .04
Treatment Total 18.76 1 18.76 5.82 .03* .63 .24
X Diet Neutrophil 344.82 1 344.82 4.04 .06 .48 .18
Lymphocyte 1159.13 1 1159.13 7.16 .02* .72 .29
Monocyte 151.33 1 151.33 3.46 .08 .42 .16
Eosinophil 3.41 1 3.41 5.78 .03* .62 .24
Basophil 2.33 1 2.33 2.81 .11 .36 .14
Error Total 58.072 18 3.23
Neutrophil 1536.23 18 85.35
Lymphocyte 2912.90 18 161.83
Monocyte 788.23 18 43.79
Eosinophil 10.60 18 .59
Basophil 14.92 18 .83
Note. *= p <j 
For the
05.
found, F(l, 
implanted 
serve to help 
For the 
found, F (1,
measurement of neutrophil percentage, a significant effect of Treatment was 
18) = 12.09, p = .00 with a significantly greater percentage in corticosterone- 
imals (M = 31.76) than sham-surgery animals (M = 17.52). Neutrophils 
defend against bacteria.
rcentage of eosinophils, a significant Treatment X Diet interaction was 
18) = 5.78, p = .03. Subsequent analysis revealed that the sham-surgery,
ah
pe
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Zinc-deprived animals (M = 2.06) had a significantly greater eosinophil percentage than 
the sham-surgery, zinc-adequate animals (M = .63), the corticosterone-implant, zinc- 
adequate animals (M = 1.26) and the corticosterone implant, Zinc-deprived animals (M= 
1.06). Eosinpphils contribute to the allergic response (see table 13).
To comphre the white blood cell values with the normal values, the mean normal value 
plus/minus the standard deviation was compared against the counts obtained in this study. 
For neutrophil percentage, the implant, zinc-adequate (M = 33.86) animals were at least 
one SD aboye normal, whereas the sham-surgery, zinc-adequate (M = 11.39) animals 
were at leas) one SD below the normal mean.
Zinc
For lym 
surgery, 
mean. The 
mean and 
above the m
the
till
For moni 
mean with 
the normal 
from the me 
most from
phocyte percentage the implant, Zinc-deprived (M = 58.34) and the sham- 
-deprive^ v; ' animals were at least one SD below the normal
implant, zinc adequate animals (M = 52.11) was at least two SD below the 
sham-surgery, zinc-adequate (M = 80.43) animals were at least one SD
ean.
cfcyte percentage, all of the groups were at least two SD above the normal 
e sham-surgery, Zinc-deprived animals (M = 16.33) deviating the most from 
rhean. For basophil percentage, all of the animals deviated at least one SD 
an with the sham-surgery, Zinc-deprived animals (M = 1.53) deviating the
the mean.
Brain Histology
Three animals from each group were randomly selected for analysis of effects of 
treatment ori the hippocampus. For each animal, three sections were examined. The 
CA3 area which is just beyond the curve in the hippocampus was selected on each
section. Th< 
ocular ruler 
area), if it w 
the boundar 
taking three 
were counte
Table 14. W
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i number of complete cells were counted within the boundaries on an intra- 
(125pm). A cell was counted if it was complete with a visible nucleus (white 
as attached to the pyramidal cell layer band and if the entire cell fell within 
es of the area being counted. Pyramidal layer width was determined by 
measurements in the area that was counted using an intra-ocular ruler. Cells 
d and width was measured at 40x power and was done blind to condition.
idth Measurement of CA3 Section of Hippocampus by Treatment
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequ
' K ) . - <
ate 70.93 pm 88.33 pm 
(6.67) (10.29)
.icpriv id 74.63 pm 93.15 pm 
(5.28) (25.91)
Note. Parer
All nine 
animal) for 
numbers we 
width and c< 
Table 15. C
theses indicate standard deviation.
neasurements for each rat (3 measurements for each slice X three slices per 
:ell count and pyramidal band width were averaged and these averaged 
re used for analysis. Means and standard deviations for pyramidal band 
:11 count are in tables 14 and 15. 
dl Count of a 125 pm Section of CA3 Hippocampus
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequate 26.11 pm 26.63 pm 
(1.49) (1.19)
Zinc-depriv id 27.78 pm 28.78 pm 
(2.03) (2.84)
Note. Parentheses indicate standard deviations.
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Table 16. Sc urce Table for CA3 Hippocampus Width Measurement
Source SS df MS Prob. Power Eta
Treatment 968.00 1 868.00 4.56 .065 .47 .36
Diet 54.42 1 54.42 .26 .63 .07 .03
Treatment X Diet .93 .93 .00 .95 .05 .00
Error 1699.07 8 212.38
A 2 (Trect 
measurement 
size and the 
width measii: 
(see tables 
band (log 10 
and 3). A 2f 
effects.
ment) X 2 (Diet) between subjects ANOVA on the average width 
s resulted in no significant differences (see table 16). Due to low sample 
potential for large variability between subjects a loglO transformation on the 
rement resulted in a significant effect of Treatment, F (1,8) = 5.46, p -  . >-3 
and 18). The sham surgery animals had a significantly wider pyramidal 
M = 1.952) than the corticosterone animals (loglO M = 1.86) (see Figures 2 
Treatment) X 2 (Diet) ANOVA of the cell counts revealed no significant
17
Table 17.Lo 
Tre
l  10 Transformed Width Measurement of CA3 section of Hippocampus by
atment
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequate 1.85 pm 
(.04)
1.94 pm 
(.05)
Zinc-deprive d 1.87 pm
(.03)
1.96 pm
( .11)
Note. Paren heses indicate standard deviation.
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Figure 6. Photomicrograph of Hippocampus Section (40X) of an 
Implant/Zinc-Deprived Animal.
Circled area indicates section that was uk, „ ox CA3. 
Table 19. Width Measurement of CA1 section of Hippocampus by Treatment
Treatment Condition
Corticosterone-Implant Sham-Surgery
Zinc-Adequate 47.87 pm 
(11.44)
55.92 pm 
(4.01)
Zinc-deprived 60.28 pm 
(26.28)
68.62 pm 
(13.45)
Note. Parentheses indicate standard deviation.
For the analysis of the zinc concentration of brain sections the raw data provided by 
LaBuda and Frederickson of Neurobiotex, Inc. included the measurement of the TSQ 
fluorescence) intensity for 10 sections for each animal for each of the following brain 
areas: hippocampus hilus, hippocampus CA1, hippocampus CA3, cortex and the
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Table 16. Sburce Table for CA3 Hippocampus Width Measurement
Source SS df MS Prob. Power Eta
Treatment 968.00 1 868.00 4.56 .065 .47 .36
Diet 54.42 1 54.42 .26 .63 .07 .03
Treatment X Diet .93 .93 .00 .95 .05 .00
Error 1699.07 8 212.38
measurements
A 2 (Treatment) X 2 (Diet) between subjects ANOVA on the average width
resulted in no significant differences (see table 16). Due to low sample 
potential for large variability between subjects a log 10 transformation on the 
urement result1?'3 V ' i^cant effect of Treatment, F (1,8) = 5.46, p = .048 
l|7 and 18). The sham surgery animals had a significantly wider pyramidal 
M = 1.952) than the corticosterone animals (log 10 M = 1.86) (see Figures 2 
(Treatment) X 2 (Diet) ANOVA of the cell counts revealed no significant
size and the 
width meas 
(see tables 
band (log 10 
and 3). A 2< 
effects.
Table 17. Log 10 Transformed Width Measurement of CA3 section of Hippocampus by 
Treatment
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequate 1.85 pm 
(.04)
1.94 pm 
(.05)
Zinc-deprived 1.87 pm 
(.03)
1.96 pm 
( - 11)
Note. Parentheses indicate standard deviation.
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Table 18. Source Table for LoglO Transformed Width Measurement
Source SS df MS F Prob. Power Eta2
Treatment .02 1 .02 5.46 .048* .54 .41
Diet .00 1 .00 .23 .64 .07 .03
Treatment 3 Diet .00 1 .00 .01 .92 .05 .00
Error .04 8 .00
Note. * =p <.05.
figure 5. Photomicrograph of Hippocampus Section (40X) of a Sham- 
surgery/Zinc-Adequate Animal.
Circled area indicates section that was measured of CA3.
The width of the CA1 area of the hippocampus was measured using the same
procedure as for the CA3 area. A 2 (Treatment) X 2 (Diet) ANOVA of the width 
measurements resulted in no significant differences for treatment, diet or the interaction
of treatment X diet. Means and standard deviations are in table 19.
thalamus wa: 
from the ori 
The measun 
the pool of \ 
averaged for 
analysis. 
Table 20. M
ginal
s used. Background fluorescence was also measured and then subtracted 
intensity measurements resulting in an adjusted intensity measurement, 
^ment of intensity indicates the amount of vesicular zinc staining reflecting 
esicular zinc in that particular area. The 10 sections for each brain area was 
each animal and this number adjusted for background, was used in the 
ans and standard deviations are presented in table 20.
2an Adjusted Cortex TSQ Fluorescence Intensity by Treatment
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Me,
Treatment Condition
Corticosterone-Implant Sham-Surgery
Zinc-Adequate 19.73
(7.61)
16.76
(8.64)
Zinc-deprived 20.71
(6.17)
26.83
(4.07)
Note. Parentheses indicate standard deviation.
A 2 (Tre 
the adjusted 
Zinc-deprive 
animals (M 
Table 21. So
altment) X 2 (Diet) ANOVA resulted in a significant main effect of Diet for 
measurement of the Cortex, F (1, 32)= 4.72, p = .04 (see table 21) with the 
d animals exhibiting more vesicular zinc (M = 23.77) than the zinc-adequate 
¥  18.24). No other measurements were significant.
Me i:
urce Table for Mean TSQ Fluorescence Intensity of Adjusted Cortex 
surement
Source SS df MS Prob. Power Eta
Treatment 20.53 20.53 .38 .54 .09 .01
Diet 252.58 252.58 4.72 .04* .56 .13
Treatment XI Diet 170.72 1 170.72 3.19 .08 .41 .09
Error 1712.11 32 53.50
Note. *=p<.05.
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A square 
cortex meas 
significant 
Table 22. Mi
root transformation was also done, the means and standard deviations for the 
urement is in table 22. A 2 (Treatment) X 2 (Diet) ANOVA resulted in no 
differences.
ean Adjusted Square Root Transformed Cortex TSQ Fluorescence Intensity 
o y  Treatment
Treatment Condition
Corticosterone Implant Sham Surgery
Zinc-Adequate 4.67
(.32)
3.97
(.30)
Zinc-deprived 4.50
(.36)
5.17
(.39)
Note. Parentheses indicate standard deviation.
Table 23. Source Table for Mean Adjusted Square Root 
Fluorescence Intensity
 ^Cortex TSQ
Source SS df MS Prob. Power Eta
Treatment .00 .00 .00 .95 .05 .00
Diet 2.04 2.04 2.29 .14 .31 .08
Treatment X Diet 3.62 1 3.62 4.06 .05 .49 .13
Error 1712.11 32 53.50
Note. * =p ]<.06.
Long-term Activity
Long-terjn activity was measured in the animal’s home cages using Coulbourn 
Instruments 22-hour Home Cage Activity Monitoring System. Activity was measured for 
two consecutive days during each session and occurred in two sessions, during weeks 2 
and 10 of treatment. Monitoring began at 9:00 A.M. and ended between 8:00 and 9:00 
A.M. the next day.
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Variables measured included time spent in no movement, small movement (greater
than 0 seconds minimum criterion duration) and large movement (.5 seconds criterion
duration). The number of incidents of no movement, small and large movement was also
calculated.
Due to 
per session, 
animals, 
total activity 
session, both
only
problems with the software, the activity program measured roughly 16 hours 
In order to ensure total measurement of activity was consistent across 
the first 450 2-min intervals for each day were used in this analysis. The 
time and incidence for each variable was calculated for each day. For each
t
days were combined resulting in an overall measurement for each of the
two session'. Means and standard deviations are shown in tables 24 (total movement)
and 25 (tota 
Table 24. M
time).
* 1
ean Total Movement on Long-term Activity: Treatment X Diet
Treatment = Corticosterone Implant
Dietary Condition
Zinc-Adequate Zinc-deprived
Session 1 Session 2 Session 1 Session 2
Small Movement 6160.35 5571.82
(1137.38) (774.51)
Large Movement 3419.12 3447.71
(786.12) (746.81)
5970.33 5074.44
(845.31) (795.51)
3558.44 3376.22
(790.23) (924.58)
Treatment = Sham Surgery
Zinc-Adequate Zinc-deprived
Session 1 Session 2 Session 1 Session 2
Small Movement 6180.50 5295.94
(858.00) (691.40)
Large Movement 3482.56 3417.50
(745.44) (594.65)
5590.78 5246.11
(942.10) (832.05)
2990.56 3318.89
(669.37) (992.54)
N ote. S tandard  dev ia tions are in parenthesis.
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A 2(Trea ment) X 2 (Diet) X 2 (Time) mixed ANOVA for the total small movements
during a session resulted in a main effect for Time, F (1, 49) = 38.35, g = .00 with
animals exh biting more small movements in session one (M = 5975.49) than session two
(M = 5297.08). A 2(Treatment) X 2(Diet) X 2 (Time) mixed ANOVA was calculated
for total time spent in small movements. A significant main effect of time was found, F
(1, 49) = 41.92, g = .00 with more time spent in small movements during session one (M 
= 2093.02) than session two (M = 1794.11).
Table 25. Mean Total Time on Long-Term Activity: Treatment X Diet
Treatment = Corticosterone Implant
Dietary Condition
Zinc-adequate Zinc-deprived
Session 1 Session 2 Session 1 Session 2
No Movement 97288.94
(2615.45)
96240.06
(2723.28)
96552.11
(2875.72)
96031.33
(3235.91)
Small Moverm :nt 2173.12
(461.67)
1897.82
(299.76)
2092.44
(338.71)
1724.78
(300.93)
Large Moverm ;nt 7817.94
(2249.11)
9142.12
(2505.22)
8635.44
(2690.01)
9523.89
(2975.53)
Treatment = Sham Surgery
Zinc-adequate Zinc-deprived
Session 1 Session 2 Session 1 Session 2
No Movement 96516.06
(2811.61)
95731.22
(3042.20)
98527.89 96340.00
(2239.60) 3897.39)
Small Movement 2161.83 1770.40
(354.23) (259.70)
Large Movement 8602.11 9778.39
(2518.73) (2821.56)
1944.67 1783.44
(377.13) (338.13)
6807.44 9156.56
(1907.33) (3628.50)
Note. Standard deviations are in parenthesis.
A 2(Treai:ment) X 2(Diet) X 2 (Time) mixed ANOVA was also calculated separately
for total largje movements and total time spent in large movements. A significant main
5 0
effect for total time spent in large movements was found, F( 1, 49) = 18.18, g =.00 with a 
greater amount of time spent in session two (M = 9400.24) than session one (M = 
7965.74). b|o significant differences were found for total large movements.
A 2(Trea:ment) X 2(Diet) X 2 (Time) mixed ANOVA was also calculated time spent 
ent. A significant main effect of time spent in small movements was found, 
.74, g = .00 with greater time in session one (M = 97221.25) than session 
085.65).
an Square Root Transformed Total Small Movement: Treatment X Diet
in no movem 
F (1, 49) 
two (M = 96 
Table 26. Me;
Dietary Condition
Zinc-adequate Zinc-degrived
Session 1 Session 2 Session 1 Session 2
Corticosterone-Implant 78.16
(7.38)
74.47
(5.26)
77.11
(5.31)
71.04
(5.57)
Sham-Surgery 78.43
(5.53)
72.63
(4.73)
74.54
(6.30)
72.22
(5.90)
Note. Parentheses indicate standard deviations.
ITli
A square 
(Treatment) 
main effect 
exhibiting 
72.59). A si 
F(l,49) = 4.
Subseque: 
small move: 
animals had
root transformation was done on total small movements (see table 26). A 2 
X 2 (Diet) X 2 (Time) mixed ANOVA was again calculated and a significant 
|)f time was again found, F (1,49) = 39.30, g = .000 with animals again 
ore small movements during session one (M = 77.06) than session two (M = 
gnificant three-way interaction of Treatment X Diet X Time was also found, 
22, g = .045 (see table 27).
nt t-test (2-tailed) analysis resulted in several significant differences for total 
ments. The corticosterone-implanted, zinc-adequate and Zinc-deprived 
significantly more small movements during session one (zinc-adequate
Zi
Zi
sh
nc-deprived M = 77.11) than session two (zinc-adequate M = 74.47; Zinc- 
71.04). During session two the corticosterone- implanted zinc-adequate 
= 74.47) had significantly more small movements than the corticosterone- 
nc-deprived animals (M = 71.04).
am surgery animals, the zinc-adequate animals had significantly more small 
during session one (M = 78.43) than session two (M = 72.63). The sham- 
-adequate animals (M = 78.43) also had more small movements during 
session one than the sham-surgery, Zinc-deprived animals (M = 74.55). The sham- 
surgery, zinc-adequate animals also had more small movements during session one (M = 
78.43) than the sham-surgery, Zinc-deprived animals during session two (M = 72.22).
M=78.16; 
deprived M 
animals (M 
implanted 
For the 
movements 
surgery, zinc
Table 27. Source Table for Square Root Transformed Tota
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.ent
Source SS df MS Prob. Power Eta
Time 474.77 474.77 39.30 .00* 1.00 .45
Time X Treatment 3.96 3.96 .33 .57 .09 .01
Time X Diet 1.84 1.84 .15 .70 .07 .00
Time X Treatment 50.99 
X Diet
50.99 4.22 ,045H .52 .08
Error 591.93 49 12.08
Note. *=pf.05.
Short-Term Activity
Short-term, open-field activity was measured using a Coulbourn Instruments Tru-Scan 
Monitoring System. In each one hour session, 42 variables were measured and recorded 
each second for each animal. In the apparatus, a grid of infra-red beams (16) covered the 
entire area of the cage, creating coordinates of beams with one inch between each
5 2
intersection 
break it was 
coordinate.r 
An example 
beam breaks 
and Y (direct 
were collapse  ^
intervals dun 
the beginning 
analyzed for 
time, Margin 
breaks, Vert 
time, Clock 
variables, se 
analyzed, al< 
individually
of the beams. Every time the animal crossed a beam resulting in a beam 
counted as a movement episode as the animal moved through another 
he variables consisted of various measurements resulting from beam breaks, 
would be the movement of the animal across the floor of the apparatus. The 
would take into account the movement of the animal in both the X (width) 
ion) resulting in a measurement of episodes of XY movement. All variables 
d into 5- minute intervals using means, resulting in twelve 5-min time 
ing the 60-minute session. A 1500-hertz tone was sounded for 20 seconds at 
of time interval 7, 9 and 11. Fifteen of the available variables were 
this study including XY movement and time, XY distance traveled, Margin
distance traveled' ? ' movements, Stereotypic time, Vertical
Vl* i 1 V
ical time, Front half entries, Front half time, Back half entries, Back half 
wise-revolutions and Counter-clockwise revolutions. In addition to these 
veral measurements related to the overall session nose poke task were also 
)ng with physiological measurements. These variables are presented 
below.
XY Movement Time
XY movement time is the cumulative duration of X-Y movement episodes. It is a 
measurement of the amount of time spent in horizontal movement. A 2 (Treatment) X 2 
(Diet) X 12 (Time) mixed ANOVA resulted in a significant main effect of Time, F 
(11,693) = 69.812, p = .000 with XY movement generally decreasing throughout the 
session (see Table 28).
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Table 28. Mlean XY Movement Time: Treatment X Diet
Treatment= Implant
Zinc-adequate Zinc-deprived
Treatment= Sham Surgery
Zinc-adequate Zinc-deprived
Interval 1 45.50 44.22 42.73 41.20
(8.27) (6.30) (8.06) (11.55)
Interval 2 36.28 34.22 38.79 36.68
(10.34) (12.57) (7.97) (9.87)
Interval 3 30.57 35.94 33.84 33.27
(13.35) (7.87) (11.08) (10.48)
Interval 4 30.62 30.64 33.56 29.90
(10.76) (9.87) (11.75) (13.73)
Interval 5 25.39 28.06 31.87 31.00
(13.74) (11.33) (11.72) (10.47)
Interval 6 24.90 27.30 32.75 23.27
(12.17) (8.85) (9.42) 01 .35)
Interval 7 21.42 18.12 23.05 17.62
(10.62) (10.17) (12.38) (10.78)
Inte- • NT n ” .21 15.30 22.37 15.95
> 06) (9.96) (13.37) (12.22)
Interval 9 15.57 9.38 15.94 14.07
(12.54) (6.45) (10.50) (11.00)
Interval 10 14.17 12.26 16.90 16.67
(9.68) (5.74) (11.24) (14.70)
Interval 11 13.21 13.50 18.36 15.98
(8.64) (9.09) (12.65) (10.59)
Interval 12 18.28 21.78 19.60 20.13
(9.82) (10.48) (10.34) (11.71)
Note. Parentheses indicate standard deviation.
ea:
XY Movifc: 
without at 
occasions o 
(Diet) X 12( 
movement e
XY Movement Episodes 
ment episodes is the total number of episodes of XY coordinate changes 
st one sample-interval break. It is a measurement of the number of 
f horizontal movement without the animal stopping. A 2(Treatment) X 2 
Time) mixed ANOVA resulted in a significant main effect of number of XY 
)isodes, F(11,693) = 12.578, p = .00, with the number of episodes exhibiting
a drop in me 
drop the rest 
Table 29. M
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vement after the first sound presented in 
of the session (see Table 29). 
ean XY Movement Episodes: Treatment
interval seven with a progressive 
X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 6.98 7.68 7.69 6.53
(1.54) (1.08) (1.28) (1.19)
Interval 2 8.40 9.00 8.15 8.88
(1.44) (2.08) (1.59) (1.92)
Interval 3 9.00 10.28 8.94 9.05
(2.52) (1.25) (1.95) (2.28)
Interval 4 8.77 10.10 9.08 8.55
(1.81) (2.19) (2.60) (2.91)
Interval 5 8.23 8.80 8.75 8.83
(2.87) (181) (1.95) (1.99)
Interval 6 8.30 9.60 9.63 8.33
(2.36) (2.12) (1.12) (2.87)
Interval 7 8.08 7.70 8.44 6.88
(3.09) (3.40) (3.61) (3.27)
Interval 8 7.11 6.64 8.02 6.57
(3.09) (1.58) (3.05) (3.73)
Interval 9 6.17 4.86 6.71 6.82
(3.48) (2.79) (2.69) (4.41)
Interval 10 6.23 6.46 7.28 6.20
(3.30) (2.52) (4.37) (3.98)
Interval 11 6.14 6.22 7.21 6.80
(3.22) (2.78) (3.88) (3.63)
Interval 12 8.10 8.38 8.13 7.50
(3.43) (2.59) (3.38) (3.15)
Note. Parenth< 
XY distal
:ses indicate standard deviation.
XY Distance
ice is the sum of distances between successive coordinates for each
movement e lisode. It is a measurement of how far the animal traveled. A 2 (Treatment)
X 2 (Diet) X 12 (Time) mixed ANOVA resulted in a significant main effect of XY
5 5
distance, F_(l 1, 693)= 101.81, p= 000 with distance traveled gradually decreasing
throughout t le session (see Table 30).
Table 30. Mfean XY Distance: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 66.21 59.32 55.91 60.50
(19.61) (12.13) (18.19) (25.26)
Interval 2 41.42 35.97 46.38 40.83
(16.14) (18.14) (17.19) (20.34)
Interval 3 29.46 36.06 36.17 33.72
(16.11) (14.10) (18.72) (16.47)
Interval 4 29.47 27.12 33.52 29.81
(14.54) (12.39) (17.57) (18.76)
Interval 5 23.02 24.97 33.01 28.24
(17.58) (14.23) (15.97) (14.31)
Interval 6 21.83 22.86 31.41 18.64
(14.83) (11.88) (14.87) '! )
Interval 7 16.97 13.04 19.93 12.63
(9.93) (8.62) (14.05) (8.62)
Interval 8 12.72 11.29 18.37 12.09
(9.50) (9.72) (13.98) (11.80)
Interval 9 11.89 6.01 11.40 9.66
(12.03) (4.51) (9.70) (8.96)
Interval 10 10.12 7.80 12.08 13.37
(8.09) (4.30) (9.33) (14.35)
Interval 11 9.03
(7.01)
9.29 14.10 12.71
(8.23) (12.29) (12.72)
Interval 12 13.41
( 10.01)
16.53 14.10 15.09
(9.83) (9.96) (11.19)
Note. Parentheses indicate standard deviation.
Margin Time
Margin tifne is the cumulative time spent within a 2-beam margin of the walls of the 
cage. It is a ineasurement of how much time the animal spent at the edge of the cage. A 2 
(Treatment) X 2 (Diet) X 12(Time) mixed ANOVA resulted in a significant main effect
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of time spent in the margin, F (11,693) = 9.32, p.= .00, with time spent in the margin 
gradually increasing throughout the session (see Table 31).
Table 31. M
Interval 1
Interval 2
Interval 3
Interval 4
Interval 5 
Interval 6
Interval 7 
Interval 8 
Interval 9 
Interval 10 
Interval 11 
Interval 12
;an Margin Time: Treatment X Diet
Treatment= Implant 
Zinc-adequate Zinc-deprived
23.92
(13.45)
24.97
(17.63)
32.66
(20.51)
26.27
(16.46)
27.11
(17.25)
29.73
(20.67)
28.48
(21.34)
33.21
(22.98)
33.89
(24.85)
35.72
(22.97)
33.63
(25.01)
38.26
( 21.20)
20.12
(8.14)
28.84
(16.40)
25.38
(10.33)
24.82
(14.54)
26.14
(18.16)
30.14
(24.59)
33.30
(22.12)
39.30
(22.27)
42.30
(19.94)
40.52
(20.23)
38.36
(22.35)
Treatment= Sham Surgery
Zinc-adequate Zinc-deprived
18.29 21.38
(10.31) (11.16)
20.19 22.87
(13.62) (16.42)
18.56 28.13
(15.61) (19.72)
17.68 23.47
(16.89) (16.63)
20.83 27.82
(17.93) (22.09)
24.41 34.28
(16.85) (21.03)
23.41 38.32
(19.30) (25.70)
32.46 37.97
(20.21) (24.07)
24.70 38.90
(24.14) (24.12)
31.27 38.98
(23.47) (20.41)
29.05 40.10
(23.75) (24.80)
33.68 37.20
(24.59) (22.30)
Note. Parentheses indicate standard deviation.
Margin Distance Traveled
Margin distance traveled is a measurement of the total distance traveled while within a
2-beam margin of the walls of the cage. A 2(Treatment) X 2(Diet) X 12(Time) mixed 
ANOVA resulted in a significant main effect of margin distance traveled, F (11,639) =
23.01,2 = .C 
Table 32). 
Table 32. M
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0, with margin distance traveled decreasing throughout the session (see 
;an Margin Distance Traveled: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 11.99 11.40 8.82 11.55
(5.89) (6.19) (5.63) (6.54)
Interval 2 8.84 11.08 8.38 8.22
(5.63) (5.98) (5.70) (6.05)
Interval 3 7.28 10.40 5.99 9.27
(4.26) (7.40) (4.45) (6.07)
Interval 4 6.06 6.58 5.53 7.10
(4.35) (4.07) (4.70) (6.63)
Interval 5 5.35 6.11 5.91 7.45
(4.69) (3.79) (5.68) (6.48)
Interval 6  . c 07 9.07 6.48 6.39
u . ) f ' 01) (4.36) (4.77) (4.60)
Interval 7 3.89 3.77 3.61 5.25
(3.69) (3.58) (4.08) (5.88)
Interval 8 3.28 3.87 4.68 3.75
(3.10) (3.22) (3.49) (2.98)
Interval 9 3.35 2.88 2.87 3.75
(2.90) (1.98) (3.27) (3.11)
Interval 10 3.19 4.51 3.60 5.10
(3.54) (3.33) (3.55) (5.81)
Interval 11 2.73 3.77 3.02 5.11
(2.52) (2.79) (3.12) (5.14)
Interval 12 2.87 4.50 4.62 5.61
(2.80) (4.20) (3.77) (3.71)
Note. Parenth :ses indicate standard deviation.
Stereotypic Movements
Stereotyp e movements are the total number of XY coordinate changes from, 5 to N,
after a .5 to 1 beam coordinate change that fall within + or -  1 beam of the origin of the
first movem ;nt. It is a measurement of small repetitive behavior that is characteristic of
stereotypic inovements. A 2 (Treatment) X 2 (Diet) X 12 (Time) mixed ANOVA resulted
in a signific, int main effect of Time, F (11,693) = 7.83, p = .00 with number of
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movements slowing increasing through interval 6 and then gradually decreasing during
the second tjalf of the session (see Table 33).
Table 33. Mean Stereotypic Movements Treatment X Diet
Treatment= Implant Treatment3 Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 1.80 2.20 2.00 1.62
(.93) (.71) (.80) (.59)
Interval 2 2.33 2.70 2.71 2.85
(1.09) (1.09) (1.26) (1.06)
Interval 3 2.74 2.62 3.22 2.87
(1.15) (.96) (1.44) (1.06)
Interval 4 2.80 3.30 3.06 2.67
(.99) (1.20) (1.21) (1.44)
Interval 5 2.45 2.52 2.87 4.05
(1.44) (.75) (1.44) (2.53)
Interval 6 2.66 2.96 3.51 3.05
(1.11) (.85) (1.23) (1.89)
Interval 7 2.76 2.42 2.56 3.18
(1.70) (1.02) (1.46) (2.78)
Interval 8 2.03 2.12 2.23 2.30
(1.21) (1.01) (1.32) (1.51)
Interval 9 2.22 1.18 2.16 2.15
(1.41) (.80) (1.41) (1.55)
Interval 10 1.93 1.64 2.13 2.08
(1.32) (1.32) (1.55) (1.90)
Interval 11 1.83 1.94 2.25 2.72
(1.18) (1.44) (1.82) (2.24)
Interval 12 2.27 2.98 2.55 2.58
(1.21) (1.65) (1.47) (1.21)
Note. Parentheses indicate standard deviation.
Stereotypic Time
Stereotyp c time is a measurement of the time spent in a series of stereotypic
movements separated by at least 10 sample intervals of rest. It is a measurement of time
spent in episodes of small, repetitive, stereotypic behavior. A 2(Treatment) X 2(Diet) X
12 (Time) Greenhouse-Geisser corrected ANOVA resulted in significant within-subjects
main effect of  Time, F (1.28,80.90) = 289.27, p = 00, with most time spent in stereotypic
movement occurring during the first interval and then dropping dramatically to near 0 for 
the rest of the intervals for all animals (see Table 34).
Table 34. M
5 9
an Stereotypic Time: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery 
Zinc-adequate Zinc-deprivedZinc-adequate Zinc-deprived
Interval 1 L95
(.96)
2.82
(.87)
2.22
(.96)
1.87
(.71)
.25
(.27)
Interval 2 "7T6
(•23)
"716
(•21)
.15
( .21)
.06
( -10)
Interval 3 .06
(.14)
.11
(.16)
.10
(.13)
Interval 4 .13
(.16)
707
(■11)
706
(-10)
.04
(.08)
Interval 5 708“
( .10)
709
(■17)
707“
( . 12)
.08
(1 3 )
706
(14)
703
(07)
705
(09 )
Interval 6 707
(.13)
Interval 7 703
(-08)
~0“
(0)
705“
(.13)
Interval 8 TOT
(•04)
TT
0
702“
(.06)
702“
(.06)
Interval 9 "0
(0)
" 0“
(0)
.01
(.04)
0
(0)
Interval 10 0
(0)
0
(0)
0
( 0)
0
(0)
Interval 11 0
(0)
TT"
( 0 )
.01
(.04)
"0“
( 0)
.02
(.09)
Interval 12
Note. Parentheses indicate standard deviation.
A significant three-way within-subjects interaction of Time X Treatment X Diet was 
also found, F (1.28, 80.90) = 6.04, p = .010 (see Table 35). Post-hoc t-test analysis found 
that the differences were found in first interval with Zinc-deprived/Implant animals spent 
significantly more time in stereotypic movements (M= 2.82), then Zinc-adequate/Implant 
animals (M 1.95). The Zinc-deprived/Implant animals (M= 2.82) also had significantly 
more time than Zinc-deprived/Sham-surgery animals (M= 1.87) (see Figure 4).
.04
( .10)
0
( 0)
.02
(.06)
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Table 35. Solurce Table for Mean Stereotypic Time
Source s s df MS F Prob. Power Eta2
Interval 254.31 1.28 198.06 289.27 .00* 1.0 .82
Interval X 
Treatment
1.71 1.28 1.34 1.95 .16 .32 .03
Interval X Diet 1.01 1.28 .79 1.15 .30 .20 .02
Interval X 
Treatment X Diet
5.31 1.28 4.14 6.04 .01* .75 .09
Error 55.39 80.90 .69
Note. *= p - / \ o
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□  Corticosterone-Implant Animals Zinc-deprived
Figure 7. Bar graph showing mean stereotypic episodes divided by treatment on 
Short-term activity.
Vertical Breaks
Vertical breaks are the total number of entries or rearings above the vertical place. 
Vertical breaks occur when the animal places their head and or paws above a 
predetermined height. A 2 (Treatment) X 2 (Diet) X 12(Time) mixed ANOVA resulted in 
a significant main effect of Time, F (11,693) = 11.52, p = .00 with the number of breaks
declining through the second half of the session (see Table 36).
Table 36. M
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;an Vertical Breaks: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 38.33 43.58 32.31 38.63
(15.48) (8.44) (18.13) (18.59)
Interval 2 41.37 44.88 37.37 39.73
(18.22) (7.77) (19.31) (21.82)
Interval 3 39.12 44.18 37.93 40.92
(20.73) (10.46) (22.24) (20.83)
Interval 4 40.88 45.20 37.80 39.98
(18.51) (7.98) (21.57) (21.65)
Interval 5 38.36 43.34 37.27 37.28
(20.47) (14.55) (22.43) (20.66)
Interval 6 35.77 50.34 37.01 32.68
(21.05) (5.91) (19.70) (23.91)
Interval 7 36.36 40.98 31.11 25.68
(20.12) (22.88) (25.23) (26.22)
Interval 8 34.46 30.78 22.42
(26.10) (23.92) (25.46)
Interval 9 28.90 30.50 26.67 19.83
(23.43) (27.70) (22.64) (23.52)
Interval 10 27.40 33.62 26.32 15.18
(21.72) (23.83) (24.15) (21.94)
Interval 11 30.72 41.52 32.52 22.50
(23.75) (17.32) (25.25) (25.72)
Interval 12 31.77 34.82 32.40 24.43
(22.58) (21.54) (23.74) (21.66)
Note. Parenth ;ses indicate standard deviation.
Vertical Time
Vertical time is the cumulative that any part of the animal is above the plane of the
vertical sensor ring. A 2(Treatment) X 2(Diet) 12 (Time) mixed ANOVA resulted in a
significant nlain effect of Time, F (11,693) = 8.90, p== .00 with time peaking at interval 6
and then drcpping through the end of the session (see Table 37).
Table 37. Mi :an Vertical Time:
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Treatment X Diet
Treatment3  Implant Treatment = Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 35.75 38.14 31.45 37.40
(10.77) (9.72) (13.94) (14.13)
Interval 2 41.90 41.40 39.86 40.90
(13.48) (7.28) (11.91) (18.48)
Interval 3 38.97 40.72 43.17 42.92
(16.31) (10.34) (14.79) (16.60)
Interval 4 43.63 42.66 44.05 41.83
(10.70) (7.74) (13.53) (18.74)
Interval 5 40.60 40.94 41.70 40.22
(17.14) (14.46) (15.29) (15.44)
Interval 6 37.99 48.36 42.30 38.35
(16.76) (6.88) (11.09) (19.85)
Interval 7 39.56 40.20 37.02 29.22
(16.90) (22.81) (20.96) (25.88)
Interval 8 39.56 40.20 37.02 29.22
(16.90) (22.81) (20.96) (25.88)
Interval 9 32.97 33.66 36.75 26.25
(19.25) (25.85) (20.33) (25.74)
Interval 10 30.23 30.14 30.10 23.70
(23.01) (27.77) (21.39) (24.38)
Interval 11 28.82 32.84 29.30 18.53
(21.56) (24.03) (22.98) (23.17)
Interval 12 32.62 40.62 34.81 25.38
(21.83) (17.34) (23.22) (25.09)
Note. Parenthe ses indicate standard deviation.
Front Half Entries
Front hall entries is the total number of times the animal entered the front half of the
apparatus. A difference in amount of time spent in the front of the apparatus may
indicate a di: ference in anxiety level. A 2(Treatment) X 2(Diet) X 12(Time) mixed
ANOVA resulted in a significant main effect of Time, F (11, 693) = 10.80, p = .00 with
the number c>f entries declining after the fifth interval (see table 38).
Table 38. Me
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:an Front Half Entries: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 2.16 2.22 1.82 1.67
(1.18) (1.18) (.87) (1.45)
Interval 2 1.57 .98 2.92 1.75
(1.43) (.84) (4.65) (1.45)
Interval 3 1.52 1.14 1.63 1.15
(1.83) (1.07) (1.90) (1.22)
Interval 4 1.42 1.24 1.45 1.52
(1.97) (1.22) (1.75) (2.07)
Interval 5 1.28 1.26 1.86 .95
(2.17) (1.97) (2.53) (1.58)
Interval 6 .60 .34 1.61 .37
(.85) (.55) (2.34) (.52)
Interval 7 .43 .40 1.69 .22
(.67) (1.06) (4.94) (.42)
Interval 8 .32 .30 .89
(.76) (.59) (1.86) ’ - l
Interval 9 .30 .00 .79 .03
(.77) (.00) (2.19) (.08)
Interval 10 .43 .04 .27 .42
(.98) (.13) (.62) (.60)
Interval 11 .03 .02 .48 .23
(.13) (.06) (1.07) (.63)
Interval 12 .41 .34 .40 .08
(1.28) (.43) (-86) (.20)
Note. Parenthe ses indicate standard deviation.
Front Half Time
Front hal: time is a measurement of the time spent in the front half of the apparatus
(see table 39). A 2(Treatment) X 2(Diet) X 12 (Time) Greenhouse-Geisser corrected
ANOVA resulted in a significant Time X Diet interaction, F (4.20, 264.26) = 2.93, p =
.019 (see table 40). Subsequent t-test (2-tailed) analysis revealed that, for the zinc-
adequate animals, more time was spent in the front half of the apparatus during intervals
4 (M = 38.4:1), 6 (M = 39.42), 7 (M = 41.52), 8 (M= 43.34), 9 (M = 44.71), 10 (M =
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(M
ed
43.01), 11 
Zinc-depriv 
interval 3 
were signifitj;;
(M
= 41.59) and 12 (M = 40.294) than during interval 1 (M = 31.29). For the 
group the animals spent more time in the front part of the apparatus during 
= 36.19) than during interval 6 (M = 27.32). None of the other intervals 
antly different.
Table 39. Mean Front Half Time: Treatment X Diet
Treatment= Implant 
Zinc-adequate Zinc-deprived
Treatment= Sham Surgery
Zinc-adequate Zinc-deprived
Interval 1 28.07 35.62 34.51 29.02
(10.43) (10.90) (11.59) (13.90)
Interval 2 31.64 37.10 35.41 32.12
(16.30) (18.61) (10.99) (14.24)
Interval 3 27.13 37.00 39.22 35.38
(20.97) (16.58) (16.02) (18.13)
Interval 4 34.35 31.00 42.51 30.28
(19.45) (20 ° 'v ■ (14.50) (19.89)
Interval 5 30.29 34.66 42.76 25.25
(22.65) (22.67) (13.07) (21.79)
Interval 6 33.83 33.62 45.01 21.02
(24.38) (25.05) (13.54) (25.44)
Interval 7 33.90 36.26 49.14 25.03
(25.51) (30.61) (15.48) (27.56)
Interval 8 37.57 37.24 49.11 24.35
(26.74) (28.44) (17.24) (27.82)
Interval 9 39.42 36.00 50.01 22.48
(25.53) (30.98) (19.44) (28.26)
Interval 10 37.96 35.36 48.06 24.90
(27.35) (30.50) (22.15) (27.24)
Interval 11 38.04 35.44 45.15 24.18
(28.55) (30.55) (23.40) (27.97)
Interval 12 36.26 36.14 44.33 28.62
(27.96) (26.24) (24.56) (28.18)
Note. Parentheses indicate standard deviation.
The zinc-adequate animals also spent more time in the front of the cage than the Zinc-
deprived animals during interval 6 (zinc-adequate M = 39.42; Zinc-deprived M = 27.32),
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interval 7 (zinc-adequate M = 41.52; Zinc-deprived M = 30.65), interval 8 (zinc-adequate
M = 43.34;; 'inc-deprived M = 30.80), interval 9 (zinc-adequate M = 44.71; Zinc-
deprived M = 29.24), interval 10 (zinc-adequate M = 43.01; Zinc-deprived M = 30.13),
interval 11 ( dnc-adequate M = 41.59; Zinc-deprived M = 29.81) and interval 12 (zinc-
adequate M = 40.29; Zinc-deprived M = 32.38).
Table 40. Scurce Table for Mean Front Half Time
Source SS df MS F Prob. Power Eta2
Interval 1836.38 4.20 437.80 .86 .49 .28 .01
Interval X 
Treatment
756.48 4.20 180.35 .35 .85 .13 .01
Interval X Diet 6262.78 4.20 1493.06 2.93 .02* .80 .04
Interval X 
Treatment 3
y ,  4.20 369.66 .73 .58 .24 .01
Diet
Error 134559.94 264.26 509.20
Note. * = p <.05
Back Half Entries
Back hal 'entries is the total number of times the animal entered the half of the
apparatus th it was closest to the wall. This measurement may reflect the amount of
anxiety or stress that the animal is experiencing during the session. A 2(Treatment) X
2(Diet) X ; (Time) mixed ANOVA a significant main effect of back half entries, F
(11,693)= 1 
Table 41).
1.37, g = .00, with back half entries declining throughout the session (see
Table 41. M
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;an Back Half Entries: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 2.16 2.14 1.97 1.70
(1.17) (1.14) (.85) (1.58)
Interval 2 1.66 1.02 2.79 1.90
(1.49) (.71) (4.58) (1.56)
Interval 3 1.46 1.20 1.65 1.07
(1.74) (1.09) (1.89) (1.17)
Interval 4 1.48 1.32 1.48 1.45
(2.09) (1.27) (1.68) (1.97)
Interval 5 1.24 1.14 1.85 .95
(2.22) (1.85) (2.61) (1.56)
Interval 6 .63 .34 1.60 .37
(.84) (.54) (2.36) (-53)
Interval 7 .44 .34 1.59 .20
(.67) (.94) (4.77) (.42)
Interval 8 .32 .28 .89 .37
(.73) (.56) (1.86) (.81)
Interval 9 .29 0 .83 .05
(.74) (0) (2.25) (.12)
Interval 10 .41 .04 .30 .38
(.90) (.13) (.68) (.61)
Interval 11 .06 .02 .47 .23
(.21) (.06) (1.06) (.63)
Interval 12 .39 .34 .35 .08
(1.28) (.44) (.75) (.18)
Note. Parenthe ses indicate standard deviation.
Back Half Time
Back half time is a measurement of the cumulative time spent in the back half of the
cage. An an mal which spends more time in the back half of the cage may reflect a
higher anxie y level (see Table 42). A Greenhouse-Geisser 2 (Treatment) X 2 (Diet) X
12 (Time) m xed ANOVA was calculated due violation of the assumption of sphericity as
determined 1jy Mauchly’s Test of Sphericity W =  .002, p =  .000.
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Table 42. Mean Back Half Time: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 31.93 24.38 25.50 30.98
(10.43) (10.90) (11.59) (13.90)
Interval 2 28.36 22.90 24.59 27.88
(16.30) (18.61) (10.99) (14.24)
Interval 3 32.87 23.00 20.78 24.62
(20.97) (16.58) (16.02) (18.13)
Interval 4 25.65 29.00 17.49 29.72
(19.45) (20.90) (14.50) (19.89)
Interval 5 29.71 25.34 17.24 34.75
(22.65) (22.67) (13.07) (21.79)
Interval 6 26.17 26.38 14.99 38.98
(24.38) (24.05) (13.54) (25.44)
Interval 7 26.10 23.74 10.86 34.97
(25.51) (30.61) (15.48) (27.56)
Interval 8 22.43 22.76 10.89 5.5 t  5
(26.74) (28.44) (17.24) iT t ''2 ;
Interval 9 20.58 24.00 9.99 37.52
(25.53) (30.98) (19.44) (28.26)
Interval 10 22.04 24.64 11.94 35.10
(27.35) (30.50) (22.15) (27.24)
Interval 11 21.96 24.56 14.85 35.82
(28.55) (30.55) (23.40) (27.97)
Interval 12 23.74 23.86 15.67 31.38
(27.96) (26.24) (24.56) (28.18)
Note. Parentheses indicate standard deviation.
A significant Time X Diet interaction was found, F (4.20, 264.26) = 2.93, g = .02. 
Post-hoc analysis resulted in a significant difference between diet for intervals 6,(Zinc- 
adequate M= 20.58; Zinc-deprived M= 32.68), interval 8 (Zinc-adequate M= 16.66; Zinc- 
deprived M= 29.21) and interval 9 (Zinc-adequate M= 15.29; Zinc-deprived M= 
30.76)with Zinc-deprived animals spending more time in the back half of the cage than 
zinc-adequate rats (see Table 43 and Figure 5).
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Table 43. Source Table for Mean Back Half Time
Source SS df MS ' F Prob. Power Eta"
Interval 1836.38 4.20 437.80 .86 .49 .28 .01
Interval X 
Treatment
756.48 4.20 180.35 .35 .85 .13 .01
Interval X Diet 6262.78 4.20 1493.06 2.93 .02* .80 .04
Interval X 
Treatment X Diet
1550.57 4.20 369.66 .73 .58 .24 .01
Error 134559.94 264.26 509.20
Note. * = p <.05.
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Figure 8. Bar graph showing mean time spent in back half on short-term activity.
Clockwise Revolutions
Clockwise rotations is the total number of clockwise , 360° angular direction changes 
about the cage center. Differences found in circling behavior as measured with clockwise 
and counter-clockwise movements may be indicative of brain damage. A 2 (Treatment) X 
2 (Diet) X 12(Time) mixed ANOVA resulted in a significant main effect of Time, F (11,
69
693) = 16.393, g = .00 with the number of revolutions dropping off after interval 3 to a 
very low frequency for the rest of the session (see Table 44).
Table 44. Mean Clockwise Revolutions Treatment X Diet
Treatment3 Implant Treatment3 Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 .28 .22 .22 .17
(.27) (.20) (.29) (.25)
Interval 2 .13 .08 .18 .05
(-14) (.14) (-19) (.12)
Interval 3 .08 .10 .16 .08
(.14) (.19) (.20) (.13)
Interval 4 .06 .04 .10 .07
(.11) (.08) (.15) (.18)
Interval 5 .03 .02 .15 .03
(.09) (0 6 ) (.22) (-08)
Interval 6 .07 0 .08 0
(0) (.13) (0)
Interval 7 .03 0 0 0
(.07) (0) (0) (0)
Interval 8 .02 0 .04 .03
(.06) (0) (.10) (.12)
Interval 9 .03 0 .02 .02
(.10) (0) (.06) (-06)
Interval 10 0 0 .01 .03
(0) (0) (.04) (.08)
Interval 11 0 0 .01 .03
(0) (0) (.04) (.12)
Interval 12 .01 .02 0 .03
(.04) (.06) (0) (.08)
Note. Parentheses indicate standard deviation.
Counter-Clockwise Revolutions
Counter-clockwise revolutions is a measurement of the total number of counter­
clockwise, 360° angular direction changes. A 2 (Treatment) X 2 (Diet) X 12 (Time) 
mixed ANOVA resulted in a significant main effect of Time, F (11,693)= 25.56, p = .000
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with frequency of revolutions dropping to near 0 after interval 3 (see Table 45).
Table 45. Mean Counter- Clockwise Revolutions: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Interval 1 .37 .18 .21 .35
(.29) (.22) (.27) (.33)
Interval 2 .16 .16 .15 .25
(.23) (.21) (.21) (.27)
Interval 3 .06 .06 .11 .10
(.14) (.10) (.16) (.13)
Interval 4 .07 .06 .04 .13
(.11) (.10) (.08) (.16)
Interval 5 .09 .08 .07 .08
(.17) (.10) (.12) (.14)
Interval 6 .07 .06 .03 .05
(•13) (.14) (.07) (-09)
Interval 7 .03 0 .05 0
(.08) (0) (.13) (0)
Interval 8 .01 0 .02 .02
(.04) (0) (.06) (.06)
Interval 9 0 0 .01 0
(0) (0) (.04) (0)
Interval 10 0 0 0 0
(0) (0) (0) (0)
Interval 11 0 0 .01 0
(0) (0) (.04) (0)
Interval 12 .04 0 .02 .02
(.10) (0) (.09) (.05)
Note. Parentheses indicate standard deviation.
Analysis of Interval 7: First Sound Interval
The first interval in which the 1500 Hz tone was sounded was analyzed for the effects 
of the stressor on the activity measures (see Table 46). A 2(Treatment) X 2 (Diet) 
ANOVA for the 18 variables resulted in a significant difference for front half time for the 
interaction of Treatment X Dietary group F (1,63)= 4.49, p =.04.
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Table 46. Mean Activity Measurements for Interval 7: 1st Sound Interval
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
XY Movement 8.08 7.70 8.44 6.88
(3.09) (3.40) (3.61) (3.27)
XY Movement 21.42 18.12 23.05 17.62
Time (10.62) (10.17) (12.38) (10.78)
XY Rest Time 38.58 41.88 36.95 42.38
(10.62) (10.17) (12.38) (10.78)
XY Distance 16.97 13.04 19.93 12.63
Traveled (9.93) (8.62) (14.05) (8.62)
Stereotype 2.28 1.96 2.09 2.65
Movements (1-36) (.90) (1.27) (2.03)
Stereotype 2.76 2.42 2.56 3.18
Time (1.70) (102) (1.46) (2.78)
Counter- .03 0 .05 0
Clockwise R. (.08) (0) (.13) (0)
Clockwise .03 0 0 r
Revolutions (.07) (0) (0) v'.i
Margin 3.89 3.77 3.61 5.25
Distance (3.69) (3.58) (4.08) (5.88)
Margin Time 28.48 30.14 23.41 38.32
(21.34) (24.59) (19.30) (25.70)
Front Half 33.90 36.26 49.14 25.03
Time (25.51) (30.61) (15.48) (27.56)
Front Half .43 .40 1.69 .22
Entries (.67) (1.06) (4.94) (.42)
Back Half 30.20 19.30 22.94 21.02
Time (25.96) (26.31) (24.59) (28.91)
Back Half 1.43 .14 1.27 .03
Entries (3.81) (.33) (2.38) (.08)
Vertical 36.36 40.98 31.11 25.68
Breaks (20.12) (22.88) (25.23) (26.22)
Vertical 39.56 40.20 37.02 29.22
Time (16.90) (22.81) (20.96) (25.88)
Nose Poke .93 .86 1.79 1.03
Entries (1.93) (1.07) (3.03) (1.90)
Nose Poke 2.43 .88 2.17 2.48
Time (4.95) (1.49) (4.03) (4.37)
Note. Parentheses indicate standard deviation.
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Subsequent t-test analysis (2-tailed) resulted in a significant difference for Sham 
surgery animals with a zinc-adequate diet, with sham surgery animals (M = 49.14) 
spending more time in the front half of cage than Zinc-deprived animals, sham surgery 
animals (M = 25.03).
Total Session Activity
To calculate total activity for the entire session, front half entries and back half entries 
for all 12 intervals during the 60 minute session was summed together to create a total 
activity variable. A 2 (Treatment) X 2 (Diet) ANOVA resulted in no significant 
differences (see Table 47).
Table 47. Mean Total Session Activity: Treatment X Diet
Treatment = Imp'?" Treatment= Sham Surgery
Zinc- Adequate 21.01 31.61
(14.33) (36.87)
Zinc-deprived 16.46 17.50
(12.13) (12.18)
Note. Parentheses indicate standard deviation.
Nose-Poke Task
Prior to the short-term activity monitoring task, the 16 holes in the floor were baited 
with a sucrose reinforcement pellet. The Tru-Scan Activity Monitoring program 
(Coulbourn Instruments) measured several variables related to the consumption of the 
food pellets by the animals. Task latency is the time from the start of the session until the 
animal enters the first hole. Task time is the time from the entry into the first hole until 
the animal has entered all 16 holes at least once.
Task entries is the total number of entries in all holes prior to completing the task. 
Post-task entries is the total number of entries into all holes after task completion. Novel
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hole inter-response-time (IRT) is the average time from one novel hole entry to the next 
novel hole entry. Repeats between novels is the total number of hole re-entries between 
novel hole entries. The number of pellets consumed by each animal during the session 
was also recorded. A 2 (Treatment) X 2 (Diet) ANOVA resulted in no significant 
differences for any of these variables (see Table 48).
Table 48. Mean Nose Poke Task: Treatment X Diet
Treatment= Implant Treatment^: Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Task 85.22 59.30 68.29 33.42
Latency (134.05) (55.37) (57.16) (29.91)
Task 1919.48 1949.70 2186.21 1870.25
Time (1395.76) (1423.33) (1263.93) (1383.68)
Novel Hole i 96.99 122.66 232.70
IRT (14l.5z) (89.85) (80.77) (465.45)
Task 40.65 55.80 56.04 48.83
Entries (22.46) (14.01) (26.81) (36.40)
Post-task 37.04 27.10 30.17 44.25
Entries (45.53) (33.88) (37.91) (56.82)
Repeat 26.17 36.10 37.12 29.17
Between
Novels
(18.34) (13.88) (25.59) (26.71)
Pellets 9.91 9.60 12.68 10.67
Consumed (7.77) (8.26) (6.23) (7.88)
Note. Parentheses indicate standard deviation.
Physiological Measurements during Short-Term Activity Monitoring 
After each session, the occurrence of defecatation and urination was recorded on the 
log. These measures may indicate the amount of anxiety or stress the animal experienced 
during the short-term activity session. Frequency for the occurrence of each 
measurement and non-parametric Chi-square test results are presented in tables 49 and
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50. Only dietary group was significantly different on frequency of urination with zinc- 
adequate animals having a higher frequency than Zinc-deprived animals.
Table 49. Physiological Measurements: Frequencies and Significance Tests by Diet 
Group Zinc -adequate Zinc-deprived X 2 g
Defecation 11 4 3.27 .07
Urination 27 8 10.31 .00
Table 50. Physiological Measurements: Frequencies and Significance Tests by Treatment
Group Corticosterone Implant Sham Surgery X2 E
Defecation 7 8 .07 .80
Urination 17 18 .03 .87
Radial Arm Maze
The number of pellets consumed during the training sessions and the two experimental 
sessions were recorded. The mean was calculated for the last three training sessions and 
this made up the baseline measurement. The mean for all three sessions during each of 
the two experimental sessions (session 1: week 3; session 2: week 11) was also 
calculated. Those animals which had a mean of 0 or 1 pellet consumed during the last 
three training sessions were excluded from further analysis due to a failure to leam/try the 
task (N=31 animals) (see table 51). A 2 (Treatment) X 2 (Diet) ANOVA on the baseline 
data resulted in no significant differences between groups prior to treatment.
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Table 51. Mean Pellets Consumed in Radial Arm Maze: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Baseline 5.07 3.67 4.35 5.58
(1.62) (1.73) (2.07) (1.27)
Session 1 1.13 0 .49 1.29
(baseline
covariate)
(2.13) (0) (.93) (1.56)
Session2 1.27 .22 .09 1.00
(baseline
covariate)
(2.55) (.38) (-20) (1.62)
Note. Parentheses indicate standard deviations.
A 2 (Treatment) X 2 (Diet) X 2 (Time) mixed ANOVA of the session 1 and session 2 
means also resulted in no significant differences. A 2 (Treatment) X 2 (Diet) X 2(Time) 
mixed ANCOVA on the session 1 and session 2 means with the baseline meant; n u 
covariate also resulted in no significant difference. An examination of the mean pellets 
consumed suggests that a floor effect may be affecting analysis, as the number of pellets 
consumed was very small across groups.
Table 52. Mean Square Root Transformed Pellets Consumed in Radial Arm Maze: 
Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Baseline 2.22 1.87 2.02 2.35
(.41) (.50) (.53) (.28)
Session 1 .62 .00 .46 .90
(baseline
covariate)
(.91) (00) (.55) (.74)
Session2 .57 .27 .13 .64
(baseline
covariate)
(1.02) (.47) (.28) (.82)
Note. Parentheses indicate standard deviations.
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The data was then transformed using a square root transformation to control for this 
possible floor effect and heterogeneous variance (see table 52). A 2 (Treatment) X 
2(Diet) ANOVA on the baseline means resulted in no significant differences. A 
2(Treatment) X 2(Diet) X 2(Time) mixed ANOVA for the session 1 and session 2 means 
resulted in no significant differences. A 2(Treatment) X 2(Diet) X 2(Time) mixed 
ANCOVA for the session 1 and session 2 means with the baseline measure as the 
covariate resulted in a significant Time X Treatment interaction, F (1, 31) = 4.71, p = 
.038. Post-hoc independent t-tests (2-tailed) resulted in a significant difference on 
session 1 with sham surgery rats (M = .70) consuming significantly more pellets than 
corticosterone implanted rats (M = .33). The sham surgery rats during session one (M = 
.67) also consumed significantly more pellets th' ’ rsion two (M = .35) (see
table 53).
Table 53. ANCOVA Source Table for Square Root Transformed Pellets Consumed in 
Radial Arm Maze
Source SS df MS F Prob. Power Eta2
Time .57 1 .57 3.85 .06 .48 .11
Time X Baseline .49 1 .49 3.31 .08 .42 .10
Time X Treatment .70 1 .70 4.71 .04* .56 .13
Time X Diet .14 1 .14 .93 .34 .16 .03
Time X Treatment 
X Diet
.19 1 .19 1.26 .27 .19 .04
Error 4.62 31 .15
Note. * = p <.05.
During each session the Coulbourn Instruments computer software “L2T2S” ran the 
radial arm maze including the opening and closing of guillotine doors. The software also
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recorded each time the animal entered one of the eight arms or entered the feeder by 
counting a break in an infra-red beam. For each of the three trials on each day, the total 
number of entries into all eight feeders was determined and used for analysis. Also, the 
mean number of entries for all three trials in a day was computed and used to compare 
session one with session two.
Table 54. Mean Feeder Entries for Session One Radial Arm Maze: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-Adequate Zinc-deprived Zinc-Adequate Zinc-deprived
Trial 1 4.70 0 1.47 7.63
(5.62) (0) (1.85) (6.26)
Trial 2 5.20 1.67 1.80 13.75
(8.70)
.1 i. _
(2.89) (2.57) (12.86)
Trial 3 5.60 .67 2.20 12.25
(11.15) (1.15) (3.88) (17.66)
Note. Parentheses indicate standard deviations.
Means and standard deviations for session one are presented in table 54. For session 
one, a 2 (Treatment) X 2(Diet) X 3(Time: 3 trials) mixed ANOVA resulted in a 
significant interaction of Treatment X Diet, F (1, 32) = 6.21, p = .018.
Table 55. ANOVA Source Table for Feeder Entries for Session One Radial Arm Maze
Source SS df MS F Prob. Power Eta2
Intercept 1728.24 1 1728.24 11.78 .00 .91 .27
Treatment 241.02 1 241.02 1.64 .21 .24 .05
Diet 119.87 1 119.87 .82 .37 .14 .03
Treatment X Diet 910.80 1 910.80 6.21 .02* .68 .16
Error 4696.93 32 146.78
Note. * = p <.05.
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Subsequent analysis demonstrated that the sham-surgery, Zinc-deprived animals (M =
11.21) had significantly more feeder entries than the sham surgery, zinc-adequate animals 
(M = 1.822), and the corticosterone implant, Zinc-deprived animals (M = .778). No 
within subjects significant effects were found (see table 55).
Table 56. Mean Feeder Entries for Session Two Radial Arm Maze: Treatment X Diet
Treatment^ Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Trial 1 7.20 1.33 1.00 8.38
(13.69) (1.53) (1.62) (10.91)
Trial 2 7.20 1.33 1.00 8.38
(13.69) (1.53) (1.62) (10.91)
7.50 .33 1.43 3.63
(13.79) (.58) (2.93) (9.07)
Note. Parentheses indicate standard deviations.
Table 57. Source Table for Feeder Entries for Session Two Radial Arm Maze
Source SS df MS F Prob. Power Eta2
Time 26.69 2 13.35 1.92 .15 .38 .06
Time X Treatment 13.88 2 6.94 1.00 .38 .22 .03
Time X Diet 44.43 2 22.22 3.19 .05* .59 .09
Time X Treatment 
X Diet
15.93 2 7.96 ' 1.14 .33 .24 .04
Error 431.35 62 6.96
Note. * = p <.05.
Means and standard deviations for session two are presented in table 56. For session 
two, a 2(Treatment) X 2(Diet) X 3(Time: 3 trials) mixed ANOVA resulted in a 
significant Time X Diet interaction, F (2,62) = 3.19, p = .048. Subsequent analysis
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resulted in the Zinc-deprived animals entering the pellet feeder (M = 1.98) significantly 
less on trial three than during trial one (M = 4.85) and trial two (M= 4.85). The zinc 
deficient animals during trial three (M = 1.98) also entered the pellet feeder significantly 
less than the zinc-adequate animals during trial one (M = 4.10), trial two (M = 4.10) and 
trial three (M = 4.46). No other significant effects were found (see Table 57).
Table 58. Mean Feeder Entries Radial Arm Maze: Session X Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Session One 5.17 .78 1.87 11.21
(8.30) (1.35) (2.39) (11.16)
Session Two 7.30 1.00 1.21 6.79
(13.54) (1.00) (2.07) (9.69)
T
Note. Parentheses indicate standard deviations.
The mean for all three trials for each of the two sessions was calculated and is 
presented in table 58. A 2(Treatment) X 2(Diet) X 2 (Time: session one and two) mixed 
ANOVA resulted in a significant between subjects Treatment X Diet difference, F (1, 30) 
= 4.80, p = .04.
Table 59. Source Table for Mean Feeder Entries Radial Arm Maze: Session X Treatment 
X Diet
Source SS df MS F Prob. Power Eta2
Intercept 981.97 1 981.97 9.12 .01 .83 .23
Treatment 36.74 1 36.74 .34 .56 .09 .01
Diet 14.11 1 14.11 .13 .72 .06 .00
Treatment X Diet 516.31 1 516.31 4.80 .04* .56 .14
Error 3229.52 30 107.65
Note. * = p <05.
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Subsequent analysis resulted in the sham-surgery, Zinc-deprived animals (M = 9.00) 
entering the pellet feeders significantly more times than the corticosterone-implanted, 
Zinc-deprived animals (M = .89). No other significant effects were found (see table 59).
Water Maze
Water maze testing occurred in two sessions. Session one was during week five and 
session two was during week 12. During each trial, the latency to complete the maze and 
the amount of boli (defecation) were recorded. If an animal failed to complete the maze a 
latency of 300 seconds was recorded. The video-taped trials were then scored for number 
of errors. An error was recorded when the animal deviated from the path leading to the 
end of the maze, by going through an entry way leading to a dead-end area. The last three 
training trial latencies was used as a baseline measi uiree trials for the
baseline, session one and session two were averaged providing a single mean for each 
animal for each session for latency. The three trials for session one and session two were 
averaged for errors and amount of defecation and a single mean used for each of these 
measurements. The number of trials required during training to reach criteria (2 
consecutive trials under 100 seconds) were also used in this analysis. A 2(Treatment) X 
2(Diet) ANOVA on the number of trials required to reach criteria resulted in no 
significant differences.
A 2 (Treatment) X 2(Diet) X 3 (Time; Baseline, Session one, Session two) on the 
latency to finish the maze resulted in a significant main effect of Time, F(2, 100) = 
184.52, p =.00 (see Table 60). Subsequent analysis revealed that the average latency to 
finish was significantly less during the baseline trials (M = 119.46) than during Session 
one (M = 276.36 ) and Session two (M = 270.66). A significant effect of treatment was
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also found, F (1, 50) = 4.53, 2 = -038. Subsequent analysis revealed that the 
corticosterone-implant animals had a longer latency to complete the maze (M = 236.88) 
than the sham-surgery animals (M = 207.44) (see table 61).
Table 60. Mean Water Maze Latency: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Baseline 130.60 124.48 111.13 111.63
(24.94) (21.83) (21.19) (23.98)
Session One 278.36 300.00 249.60 277.50
(39.08) (0) (90.75) (51.07)
Session Two 290.76 297.07 241.27 253.53
(35.80) (6.42) (112.82) (89.62)
Note. Parentheses ind- , Aviations.--- J<ru'
Table 61. Source Table for Water Maze Latency
Source SS df MS F Prob. Power Eta2
Treatment 31716.16 1 31716.16 4.53 .04* .55 .08
Diet 3973.87 1 3973.87 .57 .46 .11 .01
Treatment X Diet 360.28 1 360.28 .05 .82 .06 .00
Error 350448.36 50 7008.97
Note. * = p <.05.
A 2(Treatment) X 2(Diet) X 2(Time) mixed ANOVA on the error measurement 
revealed a significant main effect of Time, F(l, 48) = 29.18, p = .00. Subsequent analysis 
revealed that there were significantly more errors during session one (M = 2.68) than 
session two (M = 1.25) (see Table 62).
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Table 62. Mean Water Maze Errors: Treatment X Diet
Treatment^ Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Session One 3.16 2.19 2.72 2.67
(3.05) (.60) (2.30) (2.31)
Session Two 1.87 .93 .72 1.47
(1.96) (.81) (.59) (.69)
Note. Parentheses indicate standard deviations.
Table 63. Mean Number of Boli: Treatment X Diet
Treatment= Implant Treatment= Sham Surgery
Zinc-adequate Zinc-deprived Zinc-adequate Zinc-deprived
Session One 1.07 1.37 1.08 1.23
- • . \ i  X ,
(.65) (.53) (.60) (.79)
il/taSion Two 1.20 1.57 1.20 1.60
(.52) (.57) (.63) (.70)
Note. Parentheses indicate standard deviations.
Table 64. Source Table for Water Maze Boli
Source SS df MS F Prob. Power Eta2 -
Treatment .08 1 .08 .15 .70 .07 .00
Diet 2.81 1 2.81 5.51 .02* .63 .09
Treatment X Diet .10 1 .10 .20 .66 .07 .00
Error 25.50 50 .51
Note. * = p <.05.
A 2 (Treatment) X 2(Diet) X 2(Time) mixed ANOVA on the number of boli revealed
a significant main effect of Time, F (1, 50) = 4.61, p = .037 with significantly more boli 
during session two (M = 1.42) than during session one (M = 1.20). A significant effect of 
diet was also found, F (1, 50) = 5.51, p = .02. Subsequent analysis revealed that the
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Zinc-deprived animals (M = 1.48) had significantly more defecation than the Zinc- 
adequate animals (M = 1.14) (see Tables 63 and 64).
Relationship between Behavioral, Blood and Brain Variables 
All behavioral variables which yielded significant treatment, diet or interaction 
differences were analyzed in association with the four measurements of corticosterone 
concentration, the width measurement of the pyramidal cell band in the CA3 and CA1 
areas of the hippocampus and the measurement of zinc concentration in the hilus, CA1 
and CA3 areas of the hippocampus, the cortex and the thalamus. Bivariate correlations 
were run on each variable and significance was determined at the p = .01 level. Only 
those correlations described are those associations that were p < .01.
Several correlations were found for the measurement of long-term activity. Fo 
session one, total small movement a positive relationship was found with the XY distance 
traveled during interval 7 of the Short-term activity monitoring R(50) = .406. A negative 
relationship was found for the total small movement measure for session two and the 
measurement of zinc concentration in the CA3 area of the hippocampus R(36) = -.448.
Several correlations were found for the short-term activity measure. A positive 
association was found between the baseline measurement of plasma corticosterone 
concentration and the stereotypic movement during the first interval, R(25) = .578. The 
total activity during the short-term activity task was negatively associated with the 
baseline corticosterone measurement R(25) = -.664. The number of pellets consumed 
during the task was positively associated with the zinc concentration of the CA3 area of 
the hippocampus, R (.35) = .453 and with the measurement of total activity, R(67) = .403. 
Clockwise movement during the entire short-term activity task was positively associated
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with the measurement of defecation, R(67) = .311 and the measurement of XY distance 
during interval 7, R(67) = .509. Counter-clockwise movement during interval 7 was 
negatively associated with the zinc concentration in the cortex, R(35) = -.615 and 
positively associated with the XY distance moved during interval 7, R(67) = .509. 
Counter-clockwise movement during interval 7 was also positively associated with the 
latency to complete the water maze during session one, R(54) = .358. The incidence of 
urination during the short-term activity task was positively associated with the latency on 
the water maze task during session two, R(53) = .382. The total activity measurement 
was also positively associated with the measurement of total platelets in the blood, R(27) 
= .584.
Several correlations were found for the radial arm 1T' rive associations were
found for the corticosterone plasma concentrations and the number of pellets consumed 
in the radial arm maze. Session one pellets consumed was negatively associated with the 
baseline corticosterone measurement, R(27) = -.510 as was the session two pellets 
consumed, R(27) = -.664. The number of feeders entered during session two was also 
negatively associated with the baseline corticosterone measurement, R(27) = -.676. The 
number of pellets consumed during session two was positively associated with the width 
of the CA3 area of the hippocampus, R(12) = .766. The measurement of the zinc 
concentration of the CA3 area of the hippocampus was also positively associated with the 
number of pellets consumed during session one, R(36) = .440 during session two, R(36)
= .494. Pellets consumed was also positively associated with the amount of time spent in 
the back half during interval 6 of the short-term activity monitoring during session one, 
R(67) = .330 and session two, R(66) = .317.
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Several correlations were found for the water maze task. The number of errors during 
session one was positively associated with the zinc concentration of the CA1 of the 
hippocampus, R(29) = .473 and the zinc concentration of the CA3 area of the 
hippocampus, R(29) = .531. The latency to complete the maze was negatively associated 
with the session one boli count during session one R(54) = -.391 and during session two, 
R(52) = -.469. The session one boli count was also negatively associated with the 
number of errors during session one of the water maze task, R(54) = -.361. The boli 
count during session two was negatively associated with the latency for session two, 
R(52) = -.487. The number of errors during session two was negatively associated with 
the latency for session one, R(51) = -.392 and latency for session two, R(53) = -.654.
The percentage of neutropv ’’ ’ '^od was positively associated with the number of
errors during session two, R(23) = .532. The latency of session two was positively 
associated with the hematocrit measurement of the blood, R(21) = .549.
Several correlations were also found for the brain and blood measurements. The zinc 
concentration of the thalamus was positively correlated with the two month 
corticosterone plasma concentration, R(25) = .535. The zinc concentration of the CA3 
area of the hippocampus was positively associated with the zinc concentration of the 
hilus area of the hippocampus R(36) = .532 and the CA1 area of the hippocampus, R(36) 
= .557. The zinc concentration in the thalamus was positively associated with the 
percentage of eosinophils in the blood, R(12) = .771. The mean cell hemoglobin was 
positively associated with the corticosterone plasma measurement at one month, R(23) = 
.636. Mean cell hemoglobin was also positively associated with the percentage of 
monophils in the blood, R(22) = .679.
CHAPTER IV
DISCUSSION
Conclusions Drawn on Hypothesis One
The first hypothesis of this study was that hippocampal degeneration as a result of 
long-term GC exposure and ZnD would result in decreased long and short-term spatial 
memory in Sprague-Dawley rats with a greater decrease in memory in ZnD rats. 
Hypothesis one was tested using a short-term memory task, the radial arm maze and a 
memory task, the water maze.
Radial Arm Maze Task
Comparison of the corticosterone implanted animals with the sham-surgery 
animals resulted in the sham-surgery animals consuming more pellets than the 
corticosterone-implanted animals during session one of testing with the radial arm maze, 
which occurred after one month of treatment. This may reflect a difference in short-term 
memory during the first session. However, all results in the radial arm maze will be 
difficult to interpret as the task suffered from a floor effect with the animals responding 
very little overall with few pellets consumed and a small number of feeder entries.
Comparison of the dietary groups resulted in the finding that the Zinc-deprived 
animals consumed less pellets during session two (week 11 - third trial of the radial arm 
maze) than during the first two trials and less than the zinc-adequate animals during all 
three trials during session two of testing with the radial arm maze. This may reflect a
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difference in short-term memory after eight weeks of dietary treatment with the Zinc- 
deprived animals having an impaired memory.
An examination of the interaction of corticosterone and zinc-deprivation on the 
radial arm maze resulted in a compounding of the corticosterone treatment with the 
dietary treatment over time. During both sessions the Zinc-deprived animals with sham- 
surgery entered more feeders than the implant. Zinc-deprived animals, but during the first 
session the sham-surgery, zinc deficient animals out-performed both the sham-surgery, 
zinc-adequate animals and the corticosterone implant, Zinc-deprived animals.
These mixed results for the interaction overall reflect that a decline in 
performance was found for the implanted animals in comparison to the sham-surgery 
animals, supporting the hypothesis. However, the addition of dietary group demonstr't-' ’ - 
that a decline in overall performance was not found in the Zinc-deprived animals over the 
zinc-adequate animals and in fact during session one the zinc deficient animals performed 
better than the adequate animals.
Water Maze Task
Corticosterone treatment resulted in a longer latency to finish the maze for the 
corticosterone-implanted group as compared to the sham-surgery group. This would 
reflect a deficit in long-term memory for the animals that received corticosterone 
treatment at both testing sessions (Session one: five weeks and Session two: 12 weeks).
An examination of the effects of dietary treatment resulted in the Zinc-deprived 
group excreting more boli than the zinc-adequate animals. This may reflect a difference 
in anxiety level with the Zinc-deprived animals having a higher level of anxiety.
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There were no significant treatment X dietary interactions in the analysis of the 
water maze data. The results in general reflect a deficit in long-term memory for the 
corticosterone-implanted animals with no memory deficits found attributable to diet. The 
Zinc-deprived animals did however show more symptom of anxiety than the zinc- 
adequate animals (increased boli). These results showed support for the hypothesis only 
for the comparison of corticosterone treatment.
Conclusions drawn on Hypothesis Two
The second hypothesis of this study was that hippocampal degeneration as a result 
of long-term GC exposure and ZnD would result in degeneration of the dendrites and cell 
bodies of the hippocampus, would be apparent in the GC treated animals with more 
degeneration exhibited in the ZnD rats, and this would co • yeater deficits
found in memory than sham-surgery and zinc-adequate animals. This hypothesis was 
tested by examination of the general histology of the hippocampus and examination of 
the zinc concentration in the hippocampus, cortex and thalamus. This hypothesis was 
also tested by correlating the memory task results with the histology results to see if any 
association between them would be found.
Histology of the Brain
The histological examination of the hippocampus resulted in the sham-surgery 
group having a greater pyramidal cell layer width in the CA3 area than the 
corticosterone-implant animals. This demonstrates a degeneration of the cells in the 
hippocampus in the corticosterone-implanted animals and is in agreement with Sapolsky 
(1985). This finding also supported hypothesis two. However, absence of any
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deleterious effect of zinc on brain tissues, fails to support the interaction portion of 
hypothesis two.
The histological measurement of zinc-concentration in the brain resulted in the 
Zinc-deprived animals having a greater amount of zinc in the vesicles of the cortex than 
the zinc-adequate animals. This may reflect an attempt at conservation of zinc by the 
brain in those animals receiving the Zinc-deficient diet.
For the measurement of zinc concentration in brain tissues, only the cortex had a 
significant interaction with the sham-surgery animals consuming the Zinc-deficient diet 
having a greater concentration than the animals consuming the zinc-adequate animals. 
This appeared to be slightly modified by corticosterone treatment in that the animals with 
an implant and a zinc-adequ^t < " neater concentration than the sham-surgery
animals on a zinc-adequate diet.
Brain and Memory Correlations
For the radial arm maze, a strong association was found between consumption of 
pellets during session two and the width of the CA3 area leading to the conclusion that 
short-term memory performance was related to pyramidal cell layer width in the CA3 
area of the hippocampus. This association supports the theory that this area may be 
important in spatial memory. The zinc concentration of the CA3 area was also correlated 
with the number of pellets consumed during both session one and session two leading to 
the conclusion that an increase in zinc concentration in this area is related to an increase 
short-term spatial memory.
For the water maze task, the number of errors was correlated with the zinc 
concentration in the CA1 and CA3 areas of the hippocampus leading to the conclusion
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that an increase in errors was associated with increased zinc concentration in these areas 
of the hippocampus. It is interesting to note that the only significant dietary effects found 
on the water maze were differences in symptoms of anxiety. These results support 
hypothesis two in that some association between memory and brain histology was found.
Conclusions drawn on Activity Measurement 
In addition to the findings that were hypothesis driven, many other results were 
found in this study. Measurements of activity were included in the present study because 
they have been used as an animal model of depression (Pare, 1994). High levels of GC 
have been found to be associated with chronic depression (Sheline et al., 1996) and with 
PTSD (Bremner, 1999). Decreased generalized motor activity in an open-field, short- 
t v. •' ".oparatus has also been found in zinc-deprived rats (Gordon, 1984). In the 
present study, two activity tasks were done. The first was a long-term activity 
measurement designed to test the effects of the various treatments early and late in the 
study. The second task was a short-term activity task and designed to give a more 
complete study of the effects of treatment mid-way through the study than the long-term 
activity task.
Long-term Activity Measurement
For the long-term activity task, the animals treated with corticosterone (both diets) 
had more small movements during session one than during session two. For session two, 
the implanted, zinc-adequate animals had more small movements than the implanted, 
Zinc-deprived animals. For the sham-surgery, animals the zinc-adequate animals had 
more small movements than the Zinc-deprived animals. The appearance of a significant 
difference early in the study for the corticosterone treatment leads to the conclusion that
91
the effects of corticosterone on activity occurs early (within the first month) and is then 
compounded later in the study by zinc-deprivation with a decrease in movement found in 
the animals receiving both treatments.
Short-Term Activity Measurement
The short-term activity task during week eight resulted in several dietary 
differences. The Zinc-deprived animals spent more time in the back of the apparatus 
during the second half of the session when the stressor noise was sounded reflecting a 
possible difference in anxiety levels. They also had less clockwise movement indicating 
the possibility of brain damage (Penland, 2002). The Zinc-deprived animals also had less 
urination than the zinc-adequate animals indicating a potential difference in level of 
anxiety. In particular, during the interval containing the first stressor noise, the Zinc- r 
deprived animals had less counter-clockwise movement and XY distance movement than 
the zinc-adequate animals indicating a decrease in activity level.
Examination of the interaction between corticosterone and zinc-deprivation, the 
implanted, Zinc-deprived animals spent more time in stereotypic movements than either 
the implant/zinc-adequate or the sham-surgery/Zinc-deprived animals. The increase in 
stereotypic movements may be indicative of brain damage and it is interesting that this 
result occurred in the animals that received both treatment manipulations. During 
interval 7 when the first noise stressor occurred, the sham surgery/Zinc-adequate animals 
spent more time in the front half of the apparatus than the sham-surgery/Zinc-deprived 
animals lending support to the idea that the Zinc-deprived animals exhibited more anxiety 
symptomatic behaviors than the Zinc-adequate animals as was reflected in the water 
maze.
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Conclusions drawn on Corticosterone Plasma Measurement 
Plasma drawn at baseline, one month, two months and three months was used as a 
check for the manipulation of corticosterone treatment. However, the measurement of 
corticosterone concentration unexpectantly resulted in the implanted animals having the 
highest concentration at baseline than at the three draws taken at one month, two months 
and three months after pellet implantation. Whereas the sham-surgery animals had the 
highest concentration at the end of the study draw (three months) than the other three 
draws including baseline.
This finding is in direct conflict with Bodnoff et al. (1995), who used the same 
dosage of corticosterone as this study. Bodnoff et al. assessed corticosterone 
concentrations at 2.5 months using radioimmunoassay and r' • ’ n a range of 23-
32 pg/dl However, it appears that Bodnoff et al. did not compare their levels against a 
control group, thus leading to the question of whether control animals put in the same 
situation would have similar or less concentrations of corticosterone. In addition, 
Dawson, Kontur and Mojan (1984) compared the concentrations found when using 
radioimmunoassay (as Bodnoff et al, 1995) and using HPLC (as was done in the present 
study). Dawson et al. found consistently lower concentrations of corticosterone using the 
HPLC procedure, but these values were highly correlated with the levels found using 
radioimmunoassay. Given the differences in measurement technique it is difficult to 
draw a comparison with the Bodnoff et al. study. This difference may also be due to 
adaptation or the development of tolerance of the animal to the stress of the blood draws 
and kill with the corticosterone animals already accustomed to a level of stress and thus
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not reacting as much as the sham-surgery animals. The level of corticosterone, as a stress 
hormone is highly reactive to differences in level of stress.
The other explanation mhy lid in the animals physiological system 
accommodating the higher level of corticosterone produced by the implant and perhaps 
resulting in a shut down of the endogenous supply of corticosterone. This may have 
resulted in a lower overall corticosterone concentration. This explanation is supported by 
a study by Lin and Singer (1990), who also found lower levels in animals treated with a 
similar dose of implanted corticosterone but for ten days. The study's authors suggest 
that the level of corticosterone in the implanted animals represent only exogenous 
corticosterone exposure as the concentrations are similar to levels found in 
adrenalectomized animals with ? • \  -ry implants.
Dietary treatment also resulted in an effect on corticosterone concentrations. The 
zinc-adequate animals had the highest corticosterone concentration at three months with 
this measurement greater than the Zinc-deprived animals. The Zinc-deprived animals 
had the highest level at baseline. If the theory of habituation or endogenous 
corticosterone shut-down holds true when examining dietary results, it appears that the 
Zinc-deprived animals had less of a response to the stress of the blood draws and the 
necropsy/perfusion than the Zinc-adequate animals.
Conclusions drawn on Weight and Food Consumption 
The corticosterone-implanted animals were found to have consumed more overall 
food, which may have resulted in a higher body weight throughout the study as well as a 
higher body weight at the end of the study along with a heavier brain and liver than the 
sham-surgery animals. Some studies have shown increases in body weight and fat with
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high levels of stress (i.e. Marniemi, Kronholm, Aunola, Toikka, Mattlar, Koskenvuo & 
Ronnemaa, 2002) would concur with this study. However, this increase in weight is in 
direct conflict with Sapolsky (1985) who found a reduction in body weight and a 
relatively large mortality rate. Sapolsky used Fisher-344 rats, which may have a different 
level of susceptibility to corticosterone than the Sprague-Dawley animals used in this 
study.
The lack of findings of weight differences between the dietary groups was 
unexpected. Previous research (i.e. Gordon, 1984) has shown that rats on a zinc-deprived 
diet lose weight and so traditionally, researchers have included a pair-fed group in order 
to control for the potential effects of weight loss on behavioral measures. The pair-fed 
gror' e ’ v.' ’ive the same amount of food as a matched zinc-deprived rat but the food 
would have an adequate amount of vitamins and minerals. This study also included a 
pair-fed group due to this rationale. However, it was found approximately two-thirds of 
the way through the study that the pair-fed group was unnecessary, as there was no 
difference in weight or food consumption between the Zinc-deprived and Zinc-adequate 
animals.
Conclusions drawn on Complete Blood Count
The red-blood-cell parameters reflect the general health and ability of the blood to 
carry oxygen and excrete wastes. There was a greater red blood cell count for the zinc- 
adequate animals as compared to the Zinc-deprived animals with the Zinc-deprived 
animals having a greater mean cell volume and mean cell hemoglobin than the Zinc- 
adequate animals. This may be indicative of a macrocytic condition in the Zinc-deprived 
animals as they have less red blood cells and more volume leading to the conclusion that
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their red blood cells are greater in size. The mean cell hemoglobin was also found to be 
correlated with the corticosterone plasma measurement at one month with higher mean 
cell hemoglobin associated with greater corticosterone concentration. Latency of the 
water maze task during session two was found to be correlated with hematocrit.
Latencies increased with increases in hematocrit.
The mean platelet volume resulted in a greater volume in the sham-surgery and 
zinc adequate animals than the sham surgery/Zinc-deprived animals and the 
corticosterone-implant, Zinc-adequate animals, showing the possibility of both diet and 
corticosterone resulting in reduced mean platelet volume. Also, all of the groups had a 
smaller platelet volume than the normal mean. A reduction in platelet volume may result 
in problems with clotting. Total platelet volume was found to be correlated with the total 
activity measurement on short-term activity with a higher total platelet volume associated 
with a greater total activity.
The white-blood-cell count and the differential of the different types of white 
blood cells is indicative of general immune functioning. The overall white blood cell 
count of the sham-surgery, Zinc-adequate animals was higher than the sham- 
surgery/Zinc-deprived animals and the corticosterone/Zinc-adequate animals.
The sham surgery animals had more lymphocytes than the corticosterone group. 
More lymphocytes were found in the sham-surgery/zinc-adequate animals than the sham 
surgery/Zinc-deprived animals and these animals had more lymphocytes than either 
corticosterone group (Zinc-adequate and Zinc-deprived). This demonstrated a relatively 
strong relationship between the corticosterone treatment and decreased lymphocyte 
percentage. However, all of the groups other than the sham-surgery, Zinc-adequate group
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had less percentage of lymphocytes than the normal mean. Lymphocytes produce 
antibodies against foreign materials such as viruses and bacteria.
The corticosterone group had a greater neutrophil percentage than the sham- 
surgery group. The sham-surgery/Zinc-deprived animals had a greater neutrophil 
percentage than the sham-surgery/Zinc-adequate animals. The corticosterone-implanted, 
Zinc-adequate animals had a greater neutrophil percentage than the sham surgery, Zinc- 
adequate and Zinc-deprived animals. Neutrophils are used to combat bacteria, which may 
lead to the conclusion that the implanted animals had some sort of bacteria they were 
fighting with, perhaps as a result of the implant. The percentage of neutrophils was also 
correlated with the number of errors during session two of the water maze task with a 
greater percentage of neutrophils associated with a greater nurr ’
For eosinophil percentage the sham surgery/zinc-adequate animals had a greater 
percentage than the sham-surgery /Zinc-deprived animals and both groups of 
corticosterone treated animals. This demonstrates that the eosinophil percentage is 
reduced by zinc-deficiency and corticosterone treatment. Although all of the groups were 
within expected range of eosinophil percentage when comparing with the normal mean. 
Eosinophils are used to combat histamines or allergic reactions. The eosinophil 
percentage was also found to be strongly correlated with the zinc concentration of the 
thalamus with increases in eosinophil percentage associated with increases in Zinc 
concentration.
Limitations and Future Research Directions 
Several limitations were found this study. The greatest was the difficulty with the 
pellet implantation. The experimenter chose to use two, 200mg corticosterone pellets
97
purchased from Innovative Research (Sarasota, Florida). These pellets were very large 
and inserting them was not as simple as the company claimed. Innovative products 
claimed that the pellets could be inserted through a small slit in the upper back of the 
animal with no stitches required. The pellets were easy to insert. However, the incision 
did require staples to enclose the large pellets. There were no problems associated with 
the healing of the original incision site, instead problems with the pellets later erupting 
through the skin of the animal was the primary problem. This usually occurred through 
skin that had grown necrotic, leading to the theory that the pellets were causing a local 
infection, which affected the health of the animal’s skin. Once a pellet erupted through 
the skin, the pellet was cleaned as well as possible, using no solvents as this would have 
dissolved the pellet and it was ins^ ' the animal. This experimenter believes 
the overall problem was with infection introduced with the pellet implantation or 
developing shortly after implantation. In future studies, an antibiotic powder or some 
other treatment should be used to prevent infection around the pellet. In addition, a 
smaller size pellet may not place so much stress on the skin and the surrounding tissue 
and may not produce as many concerns. Although, pellet re-implantation was a large 
problem in the study, and overall the animals implanted with the corticosterone pellets 
did have a decrease in plasma corticosterone concentration, it did not appear to affect the 
plasma levels of corticosterone as no difference was found between those animals with 
implant problems and those whom had no re-implantation surgeries. In addition, several 
behavioral and histological effects were found due to the corticosterone treatment.
A second limitation was the failure of the animals to learn the short-term memory 
task, the radial arm maze. Prior research has utilized similar training methods (i.e. Olton
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& Samuelson, 1976) and have been successful in training the animals to enter each of the 
eight arms, retrieve a food pellet and then enter another arm without repeating an arm that 
has already been visited. The animals in this study visited very few arms during training 
and testing and consumed few pellets. Two possible explanations exist for these results. 
The first is that the animals were not fully trained and would have benefited from more 
training sessions. The animals received five days of training and it appears that those 
animals that performed the task, learned it fairly quickly in those five days. It is possible, 
that many other animals would have also learned the task if the number of training 
sessions were increased. The second possible explanation is that the animals were not 
properly motivated to complete the task. This lack in motivation may have occurred 
becaus * * ’s were not 85% body weight food-deprived as other studies have done.
The reason this procedure was not used was because one of the independent variables in 
this study is diet, specifically zinc- adequate and Zinc-deprived diets, thus not allowing 
the animals to be food deprived. A solution to this problem has been to use a reinforcer 
within the maze that is more desirable than what the animals normally consume such as 
peanut butter or fruit loops. However, again because a trace mineral, zinc was being 
manipulated, using these reinforcers was not a possible solution. A compromise was 
originally proposed in which the animals were fasted beginning at 10:00 P.M. the night 
prior to testing and then received their food after testing was over the next day. This 
procedure was done in the current study with both the radial arm maze and the short-term 
activity task. However, this does not appear to be an effective solution to this motivation 
problem. It may prove difficult to have any behavioral task that relies on food
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reinforcement used in a study with diet as a primary variable. This would explain the 
lack of studies in the trace mineral literature using food reinforcement behavioral tasks.
Another limitation was decreased statistical power due to a large amount of 
variability between animals and a small sample size. Many variables failed to reach 
significance due to this limitation. Future studies will need to include a greater number 
of animals in order to control for variability.
Several future studies are suggested. The first would be a more in-depth analysis 
of the effect of the corticosterone implants on plasma corticosterone concentrations than 
was done in the present study. After implanting four 100-mg pellets using an antibiotic 
substance to prevent infection, blood should be drawn on a weekly basis to better 
determine where in the time-line the concentration of corticosterone falls below the 
sham-surgery group and would serve to replicate this controversial finding. A 
comparison of environmental stressors with corticosterone administration to determine if 
there are differences in impact on memory and brain histology would also be of interest. 
The measurement of zinc concentration in the brain tissue of the animals along with the 
finding of no difference in weight and food consumption should also be replicated as 
these are also controversial findings and replication would strengthen these findings. 
Other animal studies of interest would include examining the interaction of corticosterone 
and zinc-deprivation on aging, startle response, EEG activity and an examination of 
potential gender differences. Human studies may examine the amount of daily or life 
stressors in the individual and compare with corticosterone concentrations, short-and 
long-term memory and dietary factors.
Moulton / Penland Zn 438 - Summary of Scheduled Activities
I
_ . . . .
02/14/2001 Animals arrive and are started on AIN-93G with 12 ppm Zn.
Animals are weighed, assigned a number and number is marked on tail. . i.................
06/23/2001 Animals are assigned to diet groups. ZnA (AIN-93M with 12 ppm Zn) _j . _ . . ... ...........
ZnD (AIN-93M with 1 ppm Zn)
ZnPF (AIN93-M with 12 ppm Zn restricted intake)
G ro u p  A
■ - - — (.— ............i .. .. - .. — . _________ _
. . — —  —j... - —  - • - 1 - — - —  — - — - .....— G ro u p  B
......  ........ ' ' ----------
................
. . . . . .  :
.....  J
.... ......... j
Date W e e k # Activity W e e k # Activity ______ . 1
6/25-6/30 Training Subset 1: Radial Arm Maze Training
'
Subset 2: Water Maze Training :
7/2 - 7/7 Training Holiday 7/4 Subset 1: Water Maze Training ;i
- - - ........... Subset 2: Radial Arm Maze Training : .; . .
7 /9 -7 -1 4 0 Begin Diet Treatment, take baseline blood draw and insert glucocorticoid pellets. Training Subset 1: Radial Arm Maze Training
Animals fasted by 4:00 P.M. day before. Animal weights (7/11) Subset 2: Water Maze Training
7 /16-7 /21 1 Animal Weights (7/18) Training Subset 1: Water Maze Training
Subset 2: Radial Arm Maze Training
7/23- 7/28 2 22-hour Activity Session 1 Subset 1: Habituation (7/23), testing (7/24-7/25) 0 Begin Diet Treatment, take baseline blood draw and insert glucocorticoid pellets
Subset 2: Habituation (7/26), testing (7/27-7/28) Animal weights (7/25) Animals fasted by 4:00 P.M. day before Animal weights (7/25)
7/30 - 8/4 3 Radial Arm Maze Session One: Rats fasted by 4:00 P.M Animal weights (8/1) 1 Animal weights (8/1)
8 /6 -8 /1 1  4
8 /1 3 -8 /1 8  5
8/20 - 8/25 6
8/27 - 9/1 7
9/3 - 9/8 8
9 /1 0 -9 /1 5  9
9/17-9 /22 10
9/24 - 9/29 11
10/ 1 - 10-6 12
10 /8 -10 /13  13
10/15-10-21  
10/22 -10/27
............. . i i
Revised 05/14/01 Patricia Moulton
Blood draws. Animals fasted at 4:00 P M day before Animal weights (8/8) 
Water Maze Session One: Path B Animal Weights (8/15)
Animal Weights (8/22)
Animal Weights (8/29)
Holiday 9/3 Blood draws. Animals fasted by 4 00 day prior 
Animal weights (9/5)
TruScan Activity Testing: Rats fasted by 4:00 day prior to testing 
Animal weights (9/12)
22-Hour Activity Session 2 Subset 1: Habituation (9/17), testing (9/18 - 9/19) 
Subset 2: Habituation (9/20), testing (9/21-9/22) Animal weights (9/19) 
Radial Arm Maze Session Two: Rats fasted by 4:00 P.M. day prior to testing. 
Animal weights (9/26)
Water Maze Session Two: Path A Animal weights (10/3)
Animals fasted by 4:00 P.M. day prior to necropsy Necropsy/ Perfusion 
Blood draws done prior to perfusion.
2 22-hour Activity Session 1 Subset 1: Habituation (8/6), testing (8/7-8/8)
Subset 2 Habituation (8/9), testing (8/10 - 8/11) Animal weights (8/8)
3 Radial Arm Maze Session One: Rats fasted by 4:00 P.M day prior to 
testing day Animal weights (8/15)
4 Blood draws. Animals fasted by 4:00 P.M day before. Animal weights (8/22)
5 Water Maze Session One: Path B. Animal weights (8/29)
6 Animal weights (9/5).
7 Animal weights (9/12)
8 Blood draws Animals fasted by 4:00 P.M. day before. Animal weights (9/19).
9 TruScan Activity Testing: Rats fasted by 4:00 prior to test day.
Animal weights (9/26).
10 22-Hour Activity Session 2 Subset 1: Habituation (10/1), testing (10/2-10/3) 
Subset 2: Habituation (10/4), testing (10/5-10/6). Animal weights (10/3)
11 Radial Arm Maze Session Two: Rats fasted by 4:00 P.M. day prior to testing. 
Animal weights (10/10)
12 Water Maze Session Two: Path A. Animal weights (10/17). ... ! - - J .... ! 4-
13 Animals fasted by 4:00 P.M. day prior to necropsy Necropsy/ Perfusion 
Blood draws done prior to perfusion.
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